AU757046B2
(en)
|
1997-07-01 |
2003-01-30 |
Warner-Lambert Company |
4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
|
US5932580A
(en)
|
1997-12-01 |
1999-08-03 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem |
PDGF receptor kinase inhibitory compounds their preparation and compositions
|
IL139080A0
(en)
|
1998-04-17 |
2001-11-25 |
Parker Hughes Inst |
Btx inhibitors and methods for their indentification and use
|
SK16352000A3
(sk)
|
1998-05-04 |
2002-07-02 |
Zentaris Ag |
Indolové deriváty, spôsob ich výroby, ich použitie na liečivá obsahujúce tieto zlúčeniny
|
OA11746A
(en)
|
1999-01-13 |
2005-05-13 |
Warner Lambert Co |
Benzoheterocycles and their use as MEK inhibitors.
|
WO2000042003A1
(en)
|
1999-01-13 |
2000-07-20 |
Warner-Lambert Company |
Benzenesulfonamide derivatives and their use as mek inhibitors
|
WO2000042002A1
(en)
|
1999-01-13 |
2000-07-20 |
Warner-Lambert Company |
Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
|
CA2348236A1
(en)
|
1999-01-13 |
2000-07-20 |
Stephen Douglas Barrett |
4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
|
WO2000056706A1
(en)
|
1999-03-19 |
2000-09-28 |
Du Pont Pharmaceuticals Company |
Amino-thio-acrylonitriles as mek inhibitors
|
GB9910577D0
(en)
|
1999-05-08 |
1999-07-07 |
Zeneca Ltd |
Chemical compounds
|
DE60017898T2
(de)
|
1999-06-09 |
2006-01-12 |
Yamanouchi Pharmaceutical Co., Ltd. |
Neuartige heterocyclische carboxamidderivate
|
GB9918035D0
(en)
|
1999-07-30 |
1999-09-29 |
Novartis Ag |
Organic compounds
|
EP1222187B1
(en)
|
1999-10-06 |
2004-09-22 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
UA74803C2
(uk)
|
1999-11-11 |
2006-02-15 |
Осі Фармасьютікалз, Інк. |
Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
|
AP1917A
(en)
|
1999-12-24 |
2008-11-12 |
Aventis Pharma Ltd |
Azaindoles
|
PT1782800E
(pt)
|
2000-01-24 |
2014-03-25 |
Genzyme Corp |
Métodos para detectar inibidores de jak3
|
ES2290117T3
(es)
|
2000-02-15 |
2008-02-16 |
Sugen, Inc. |
Inhibidores de proteina quinasa 2-indolina sustituida con pirrol.
|
US7087608B2
(en)
|
2000-03-03 |
2006-08-08 |
Robert Charles Atkins |
Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
|
WO2001068619A1
(en)
|
2000-03-15 |
2001-09-20 |
Warner-Lambert Company |
5-amide substituted diarylamines as mex inhibitors
|
AR028261A1
(es)
|
2000-03-28 |
2003-04-30 |
Wyeth Corp |
Inhibidores triciclicos de la proteina quinasa
|
AR035851A1
(es)
|
2000-03-28 |
2004-07-21 |
Wyeth Corp |
3-cianoquinolinas, 3-ciano-1,6-naftiridinas y 3-ciano-1,7-naftiridinas como inhibidoras de proteina quinasas
|
DE10017480A1
(de)
|
2000-04-07 |
2001-10-11 |
Transmit Technologietransfer |
Verwendung von Substanzen, die als MEK Inhibitor wirken, zur Herstellung eines Arneimittels gegen DNA- und RNA-Viren
|
JP2001302667A
(ja)
|
2000-04-28 |
2001-10-31 |
Bayer Ag |
イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体
|
AU2002249261A1
(en)
|
2001-03-06 |
2002-09-19 |
Axxima Pharmaceuticals Ag |
Use of mek inhibitors for treating inflammation and virus induced hemorrhagic shock
|
DE60231868D1
(de)
|
2001-04-24 |
2009-05-20 |
Purdue Research Foundation |
Folat-mimetika und deren folatrezeptorbindende konjugate
|
TWI238824B
(en)
|
2001-05-14 |
2005-09-01 |
Novartis Ag |
4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives
|
JP2004530730A
(ja)
|
2001-06-29 |
2004-10-07 |
アブ サイエンス |
腫瘍の血管新生を治療するための強力で選択的かつ非毒性のc−kit阻害剤の使用法
|
DE60223063T2
(de)
|
2001-06-29 |
2008-07-17 |
Ab Science |
C-kit inhibitoren
|
CA2452171A1
(en)
|
2001-06-29 |
2003-01-09 |
Ab Science |
Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
|
JP2005507916A
(ja)
|
2001-09-20 |
2005-03-24 |
アブ サイエンス |
細菌感染症を治療するための、強力で選択的かつ非毒性のc−kit阻害剤の使用方法
|
DE60215682T2
(de)
|
2001-09-27 |
2007-09-06 |
Smithkline Beecham Corp. |
AZAOXOINDOL DERIVATE ALS Trk PROTEIN KINASE HEMMSTOFFE ZUR BEHANDLUNG VON KREBS UND CHRONISCHEM SCHMERZ
|
US20030158195A1
(en)
|
2001-12-21 |
2003-08-21 |
Cywin Charles L. |
1,6 naphthyridines useful as inhibitors of SYK kinase
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
US7235537B2
(en)
|
2002-03-13 |
2007-06-26 |
Array Biopharma, Inc. |
N3 alkylated benzimidazole derivatives as MEK inhibitors
|
PL378635A1
(pl)
|
2002-03-13 |
2006-05-15 |
Array Biopharma, Inc. |
N3 alkilowane pochodne benzoimidazolu jako inhibitory MEK
|
DK3000810T3
(en)
|
2002-03-13 |
2017-10-16 |
Array Biopharma Inc |
N3-ALKYLED BENZIMIDAZOLE DERIVATIVE AS MEK INHIBITOR
|
ES2274234T3
(es)
|
2002-03-15 |
2007-05-16 |
Novartis Ag |
4-(4-metilpiperazin-1-ilmetil)-n-(4-metil-3(4-piridin-3-il)pirimidin -2-ilamino)fenil)-benzamida para el tratamiento de enfermedades mediadas por ang ii.
|
MXPA04011048A
(es)
|
2002-05-06 |
2005-02-17 |
Vertex Pharmaceutivals Inc |
Tiadiazol o oxasiazoles y su uso como inhibidores de proteina cinasa jak.
|
KR20050013562A
(ko)
|
2002-05-30 |
2005-02-04 |
버텍스 파마슈티칼스 인코포레이티드 |
Jak 및 cdk2 프로테인 키나아제의 억제제
|
GB0215823D0
(en)
|
2002-07-09 |
2002-08-14 |
Astrazeneca Ab |
Quinazoline derivatives
|
MXPA05000950A
(es)
|
2002-07-25 |
2005-05-16 |
Pfizer Prod Inc |
Derivados de isotiazol utiles como agentes anticancerosos.
|
KR101036866B1
(ko)
|
2002-08-02 |
2011-05-25 |
에이비 사이언스 |
2-(3-아미노아릴)아미노-4-아릴-티아졸 및 c-kit억제제로서의 이의 용도
|
ATE454378T1
(de)
|
2002-11-01 |
2010-01-15 |
Vertex Pharma |
Verbindungen, die sich als inhibitoren vonjak und anderen proteinkinasen eignen
|
CA2506773A1
(en)
|
2002-11-04 |
2004-05-21 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl-pyramidine derivatives as jak inhibitors
|
CA2507406A1
(en)
|
2002-11-05 |
2004-05-21 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of jak and other protein kinases
|
US7098332B2
(en)
|
2002-12-20 |
2006-08-29 |
Hoffmann-La Roche Inc. |
5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
|
JPWO2004080462A1
(ja)
|
2003-03-10 |
2006-06-08 |
エーザイ株式会社 |
c−Kitキナーゼ阻害剤
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
WO2005009389A2
(en)
|
2003-07-23 |
2005-02-03 |
Exelixis, Inc. |
Anaplastic lymphoma kinase modulators and methods of use
|
RU2006106267A
(ru)
|
2003-08-01 |
2006-07-27 |
Уайт Холдингз Корпорейшн (Us) |
Применение комбинации ингибитора киназы рецептора эпидермального фактора роста и цитотоксических средств для лечения и ингибирования рака
|
EP1660458B1
(en)
|
2003-08-15 |
2012-01-25 |
Novartis AG |
2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
|
EP1664021A1
(en)
|
2003-08-21 |
2006-06-07 |
OSI Pharmaceuticals, Inc. |
N-substituted benzimidazolyl c-kit inhibitors
|
MXPA06002017A
(es)
|
2003-08-21 |
2006-05-31 |
Osi Pharm Inc |
Pirazolil-amidil-bencimidazolilo n-sustituidos, ibnhibidores de c-kit.
|
ATE425977T1
(de)
|
2003-08-21 |
2009-04-15 |
Osi Pharm Inc |
3-substituierte imidazopyridinderivate als c-kit- inhibitoren
|
US7144907B2
(en)
|
2003-09-03 |
2006-12-05 |
Array Biopharma Inc. |
Heterocyclic inhibitors of MEK and methods of use thereof
|
US7538120B2
(en)
|
2003-09-03 |
2009-05-26 |
Array Biopharma Inc. |
Method of treating inflammatory diseases
|
DE10342794A1
(de)
|
2003-09-16 |
2005-04-21 |
Basf Ag |
Sekretion von Proteinen aus Hefen
|
GB0321710D0
(en)
|
2003-09-16 |
2003-10-15 |
Novartis Ag |
Organic compounds
|
EP1674452A4
(en)
|
2003-09-19 |
2007-10-10 |
Chugai Pharmaceutical Co Ltd |
NOVEL 4-PHENYLAMINO-BENZALDOXIME DERIVATIVE AND ITS USE AS MEK INHIBITOR
|
BRPI0414698A
(pt)
|
2003-09-23 |
2006-11-28 |
Novartis Ag |
combinação de um inibidor receptor de vegf com um agente quimioterapêutico
|
CA2542481A1
(en)
|
2003-10-15 |
2005-04-28 |
Osi Pharmaceuticals, Inc. |
Imidazopyrazine tyrosine kinase inhibitors
|
US7476729B2
(en)
|
2003-10-24 |
2009-01-13 |
Institut Curie |
Dbait and uses thereof
|
EP1526177A1
(en)
|
2003-10-24 |
2005-04-27 |
Institut Curie |
Nucleic acids useful for triggering tumor cell lethality
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
US7576072B2
(en)
|
2003-11-19 |
2009-08-18 |
Array Biopharma Inc. |
Heterocyclic inhibitors of MEK and methods of use thereof
|
DE102004001607A1
(de)
|
2004-01-09 |
2005-08-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittelkombinationen auf der Basis von Scopin- oder Tropensäureestern mit EGFR-Kinase-Hemmern
|
CN1934107A
(zh)
|
2004-01-30 |
2007-03-21 |
Ab科学公司 |
作为酪氨酸激酶抑制剂的2-(3-取代芳基)氨基-4-芳基-噻唑
|
CN1906167A
(zh)
|
2004-02-27 |
2007-01-31 |
卫材株式会社 |
新型吡啶衍生物及嘧啶衍生物(2)
|
ATE508129T1
(de)
|
2004-03-30 |
2011-05-15 |
Vertex Pharma |
Als inhibitoren von jak und anderen proteinkinasen geeignete azaindole
|
FR2868422B1
(fr)
|
2004-03-31 |
2006-07-14 |
Aventis Pharma Sa |
Nouveaux derives pyrrolo(2,3-b) pyridine, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
PL2168968T3
(pl)
|
2004-04-02 |
2018-02-28 |
OSI Pharmaceuticals, LLC |
Inhibitory kinazy białkowej stanowiące związki heterobicykliczne z podstawionym pierścieniem 6,6-bicyklicznym
|
CA2568756A1
(en)
|
2004-06-15 |
2005-12-29 |
Astrazeneca Ab |
Substituted quinazolones as anti-cancer agents
|
TW200616974A
(en)
|
2004-07-01 |
2006-06-01 |
Astrazeneca Ab |
Chemical compounds
|
AU2005274852B2
(en)
|
2004-07-19 |
2011-12-08 |
The Johns Hopkins University |
FLT3 inhibitors for immune suppression
|
TWI361066B
(en)
|
2004-07-26 |
2012-04-01 |
Chugai Pharmaceutical Co Ltd |
5-substituted-2-phenylamino benzamides as mek inhibitors
|
WO2007040469A2
(en)
|
2005-09-15 |
2007-04-12 |
Kosak Ken M |
Chloroquine coupled compositions and methods for their synthesis
|
WO2006024834A1
(en)
|
2004-08-31 |
2006-03-09 |
Astrazeneca Ab |
Quinazolinone derivatives and their use as b-raf inhibitors
|
MX2007002433A
(es)
|
2004-09-01 |
2007-05-04 |
Astrazeneca Ab |
Derivados de quinazolinona y su uso como inhibidores de b-raf.
|
RU2443700C2
(ru)
|
2004-09-17 |
2012-02-27 |
Вертекс Фармасьютикалз Инкорпорейтед |
Диаминотриазольные соединения, применяемые в качестве ингибиторов протеиновой киназы
|
EP1828147A1
(en)
|
2004-10-15 |
2007-09-05 |
AstraZeneca AB |
Quinoxalines as b-raf inhibitors
|
BRPI0517887A
(pt)
|
2004-11-24 |
2008-10-21 |
Novartis Ag |
combinações de inibidores de jaks
|
AU2005308956A1
(en)
|
2004-11-24 |
2006-06-01 |
Merck Serono Sa |
Novel 4-arylamino pyridone derivatives as MEK inhibitors for the treatment of hyperproliferative disorders
|
EP1831206B1
(en)
|
2004-12-01 |
2011-08-24 |
OSI Pharmaceuticals, Inc. |
N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library
|
CA2586796A1
(en)
|
2004-12-01 |
2006-06-08 |
Laboratoires Serono S.A. |
[1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
TW200634003A
(en)
|
2004-12-22 |
2006-10-01 |
Astrazeneca Ab |
Chemical compounds
|
EP1924573A1
(en)
|
2005-01-25 |
2008-05-28 |
AstraZeneca AB |
B-raf inhibitors
|
KR20070108881A
(ko)
|
2005-01-27 |
2007-11-13 |
교와 핫꼬 고교 가부시끼가이샤 |
Igf-1r 저해제
|
HUE025671T2
(en)
|
2005-02-04 |
2016-04-28 |
Astrazeneca Ab |
Pyrazolylaminopyridine derivatives useful as kinase inhibitors
|
PT1853602E
(pt)
|
2005-02-16 |
2010-08-25 |
Astrazeneca Ab |
Compostos químicos
|
ATE398613T1
(de)
|
2005-02-16 |
2008-07-15 |
Astrazeneca Ab |
Chemische verbindungen
|
NZ561000A
(en)
|
2005-02-28 |
2010-01-29 |
Japan Tobacco Inc |
Novel aminopyridine compound with Syk inhibitory activity
|
AU2006229343A1
(en)
|
2005-03-28 |
2006-10-05 |
Kirin Pharma Kabushiki Kaisha |
Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-Met autophosphorylation inhibiting potency
|
JP5204643B2
(ja)
|
2005-04-04 |
2013-06-05 |
アブ サイエンス |
置換オキサゾール誘導体、およびチロシンキナーゼ阻害薬としてのそれらの使用
|
JP4257926B2
(ja)
|
2005-04-19 |
2009-04-30 |
協和発酵キリン株式会社 |
含窒素複素環化合物
|
WO2006123113A2
(en)
|
2005-05-16 |
2006-11-23 |
Astrazeneca Ab |
Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
|
ATE539064T1
(de)
|
2005-05-18 |
2012-01-15 |
Array Biopharma Inc |
Heterozyklische inhibitoren von mek und verwendungsverfahren damit
|
US7541367B2
(en)
|
2005-05-31 |
2009-06-02 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
WO2006133417A1
(en)
|
2005-06-07 |
2006-12-14 |
Valeant Pharmaceuticals International |
Phenylamino isothiazole carboxamidines as mek inhibitors
|
US20070021435A1
(en)
|
2005-06-10 |
2007-01-25 |
Gaul Michael D |
Aminopyrimidines as kinase modulators
|
TW200738638A
(en)
|
2005-06-23 |
2007-10-16 |
Merck & Co Inc |
Tyrosine kinase inhibitors
|
US8207186B2
(en)
|
2005-06-23 |
2012-06-26 |
Merck Sharp & Dohme Corp. |
Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase MET
|
TW200740820A
(en)
|
2005-07-05 |
2007-11-01 |
Takeda Pharmaceuticals Co |
Fused heterocyclic derivatives and use thereof
|
US8163767B2
(en)
|
2005-07-14 |
2012-04-24 |
Astellas Pharma Inc. |
Heterocyclic Janus Kinase 3 inhibitors
|
US20080207572A1
(en)
|
2005-07-14 |
2008-08-28 |
Ab Science |
Use of Dual C-Kit/Fgfr3 Inhibitors for Treating Multiple Myeloma
|
PE20070362A1
(es)
|
2005-07-15 |
2007-04-23 |
Glaxo Group Ltd |
COMPUESTOS DERIVADOS DE INDAZOL-4-IL-2,4-PIRIMIDINDIAMINA COMO INHIBIDORES DE TIROSINA QUINASA (QUINASA Syk)
|
WO2007028445A1
(en)
|
2005-07-15 |
2007-03-15 |
Glaxo Group Limited |
6-indolyl-4-yl-amino-5-halogeno-2-pyrimidinyl-amino derivatives
|
EP1912636B1
(en)
|
2005-07-21 |
2014-06-25 |
Ardea Biosciences, Inc. |
N-(arylamino)-sulfonamide inhibitors of mek
|
US7820664B2
(en)
|
2007-01-19 |
2010-10-26 |
Bayer Schering Pharma Ag |
Inhibitors of MEK
|
WO2007023768A1
(ja)
|
2005-08-24 |
2007-03-01 |
Eisai R & D Management Co., Ltd. |
新規ピリジン誘導体およびピリミジン誘導体(3)
|
EP1922310A2
(en)
|
2005-09-07 |
2008-05-21 |
Rigel Pharmaceuticals, Inc. |
Triazole derivatives useful as axl inhibitors
|
FR2891273B1
(fr)
|
2005-09-27 |
2007-11-23 |
Aventis Pharma Sa |
NOUVEAUX DERIVES BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE NOTAMMENT COMME INHIBITEURS DE CMet
|
ATE534293T1
(de)
|
2005-09-27 |
2011-12-15 |
Irm Llc |
Diarylaminhaltige verbindungen und zusammensetzungen und deren verwendung als modulatoren von c-kit-rezeptoren
|
CA2927656C
(en)
|
2005-10-07 |
2019-09-24 |
Exelixis, Inc. |
Mek inhibitors and methods of their use
|
BRPI0617241A2
(pt)
|
2005-10-13 |
2016-11-08 |
Glaxo Group Ltd |
composto ou um sal ou solvato do mesmo, composição farmacêutica, método para tratar uma doença ou condição mediada por atividade syk inadequada em um mamífero, e, uso de um composto ou um sal ou solvato farmaceuticamente aceitável do mesmo
|
SI1963302T1
(sl)
|
2005-12-05 |
2013-04-30 |
Pfizer Products Inc. |
Polimorfne oblike inhibitorja c-met/hgfr
|
SI2455382T1
(sl)
|
2005-12-13 |
2017-03-31 |
Incyte Holdings Corporation |
S heteroarilom substituirani pirolo(2,3b)piridini in pirolo(2,3-b)pirimidini kot zaviralci janus kinaze
|
EP1979002A2
(en)
|
2005-12-19 |
2008-10-15 |
OSI Pharmaceuticals, Inc. |
Combination of igfr inhibitor and anti-cancer agent
|
WO2007071951A1
(en)
|
2005-12-21 |
2007-06-28 |
Astrazeneca Ab |
Tosylate salt of 6- (4-br0m0-2-chl0r0phenylamin0) -7-fluoro-n- (2-hydroxyethoxy) -3-methyl-3h-benzimi dazole- 5 - carboxamide , mek inhibitor useful in the treatment of cancer
|
BRPI0620462A2
(pt)
|
2005-12-22 |
2011-11-16 |
Astrazeneca Ab |
composto, processo para preparar um composto, composição farmacêutica, uso de um composto, e,métodos para produzir um efeito inibidor de b-raf e um efeito anti-cáncer em um animal de sangue quente, e para tratar uma doença
|
CA2636189A1
(en)
|
2006-01-17 |
2007-07-26 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of janus kinases
|
FR2896503B1
(fr)
|
2006-01-23 |
2012-07-13 |
Aventis Pharma Sa |
Nouveaux derives soufres d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
FR2896504B1
(fr)
|
2006-01-23 |
2012-07-13 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
WO2007085540A1
(en)
|
2006-01-27 |
2007-08-02 |
Glaxo Group Limited |
1h-indaz0l-4-yl-2 , 4-pyrimidinediamine derivatives
|
GB0601962D0
(en)
|
2006-01-31 |
2006-03-15 |
Ucb Sa |
Therapeutic agents
|
TW200740776A
(en)
|
2006-02-06 |
2007-11-01 |
Osi Pharm Inc |
N-phenylbenzotriazolyl c-kit inhibitors
|
WO2007111904A2
(en)
|
2006-03-22 |
2007-10-04 |
Vertex Pharmaceuticals Incorporated |
C-met protein kinase inhibitors for the treatment of proliferative disorders
|
EP2007736A1
(en)
|
2006-04-05 |
2008-12-31 |
AstraZeneca AB |
Substituted quinazolines with anti-cancer activity
|
US8741912B2
(en)
|
2006-04-05 |
2014-06-03 |
Vertex Pharmaceuticals Incorporated |
Deazapurines useful as inhibitors of Janus kinases
|
CN101415688A
(zh)
|
2006-04-05 |
2009-04-22 |
阿斯利康(瑞典)有限公司 |
具有b-raf抑制活性的喹唑啉酮衍生物
|
US20090203718A1
(en)
|
2006-04-13 |
2009-08-13 |
Smithkline Beecham (Cork) Ltd. |
Cancer treatment method
|
EP2012786B1
(en)
|
2006-04-18 |
2010-10-06 |
Ardea Biosciences, Inc. |
Pyridone sulfonamides and pyridone sulfamides as mek inhibitors
|
CN101421253A
(zh)
|
2006-04-18 |
2009-04-29 |
阿斯利康(瑞典)有限公司 |
喹唑啉-4-酮衍生物、其制备方法及含有它们的药用组合物
|
BRPI0711625A2
(pt)
|
2006-04-19 |
2011-12-06 |
Serono Lab |
derivados de arilaminopiridina substituìda por heteroarila como inibidores de mek
|
MX2008013400A
(es)
|
2006-04-19 |
2008-11-10 |
Astellas Pharma Inc |
Derivado de azolcarboxamida.
|
NZ572200A
(en)
|
2006-04-20 |
2011-09-30 |
Janssen Pharmaceutica Nv |
Method of inhibiting c-kit kinase
|
US20090306214A1
(en)
|
2006-05-09 |
2009-12-10 |
Eliahu Kaplan |
Use of Syk Tyrosine Kinase Inhibitors for the Treatment of Cell Proliferative Disorders
|
JP5190361B2
(ja)
|
2006-05-18 |
2013-04-24 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
甲状腺癌に対する抗腫瘍剤
|
WO2008005877A2
(en)
|
2006-06-30 |
2008-01-10 |
Board Of Regents, The University Of Texas System |
Inhibitors of c-kit and uses thereof
|
TW200813021A
(en)
|
2006-07-10 |
2008-03-16 |
Merck & Co Inc |
Tyrosine kinase inhibitors
|
ES2338278T3
(es)
|
2006-07-20 |
2010-05-05 |
Amgen Inc. |
Derivados de benzo(d)isoxazol como inhibidores de c-kit tirosina quinasa para el tratamiento de enfermedades asociadas con la sobreproduccion de histamina.
|
TW200817409A
(en)
|
2006-08-04 |
2008-04-16 |
Takeda Pharmaceutical |
Fused heterocyclic derivative and use thereof
|
WO2008020203A1
(en)
|
2006-08-17 |
2008-02-21 |
Astrazeneca Ab |
Pyridinylquinaz0linamine derivatives and their use as b-raf inhibitors
|
CA2660842C
(en)
|
2006-08-18 |
2012-03-13 |
F. Hoffmann-La Roche Ag |
Polyconjugates for in vivo delivery of polynucleotides
|
ATE535520T1
(de)
|
2006-08-23 |
2011-12-15 |
Eisai R&D Man Co Ltd |
Salz eines phenoxypyridinderivats oder kristall davon und verfahren zu dessen herstellung
|
CL2007002617A1
(es)
|
2006-09-11 |
2008-05-16 |
Sanofi Aventis |
Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
|
ES2584331T3
(es)
|
2006-09-22 |
2016-09-27 |
Pharmacyclics Llc |
Inhibidores de tirosina cinasa de Bruton
|
WO2008045978A1
(en)
|
2006-10-10 |
2008-04-17 |
Rigel Pharmaceuticals, Inc. |
Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors
|
WO2008046802A1
(en)
|
2006-10-16 |
2008-04-24 |
Novartis Ag |
Phenylacetamides useful as protein kinase inhibitors
|
EP2108642A1
(en)
|
2006-10-17 |
2009-10-14 |
Kyowa Hakko Kirin Co., Ltd. |
Jak inhibitor
|
TW200829566A
(en)
|
2006-12-08 |
2008-07-16 |
Astrazeneca Ab |
Chemical compounds
|
EP2101759B1
(en)
|
2006-12-14 |
2018-10-10 |
Exelixis, Inc. |
Methods of using mek inhibitors
|
WO2008076143A1
(en)
|
2006-12-18 |
2008-06-26 |
Osi Pharmaceuticals, Inc. |
Combination of igfr inhibitor and anti-cancer agent
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
WO2008080134A2
(en)
|
2006-12-22 |
2008-07-03 |
Rigel Pharmaceuticals, Inc. |
4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors
|
EP2114941B1
(en)
|
2006-12-22 |
2015-03-25 |
Astex Therapeutics Limited |
Bicyclic heterocyclic compounds as fgfr inhibitors
|
EP2114954B1
(en)
|
2006-12-29 |
2013-02-13 |
Rigel Pharmaceuticals, Inc. |
Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
|
WO2008083356A1
(en)
|
2006-12-29 |
2008-07-10 |
Rigel Pharmaceuticals, Inc. |
Substituted triazoles useful as axl inhibitors
|
EP2484679B1
(en)
|
2006-12-29 |
2016-09-28 |
Rigel Pharmaceuticals, Inc. |
N3-heteroaryl substituted triazoles and n5-heteroaryl substitued triazoles useful as axl inhibitors
|
WO2008083357A1
(en)
|
2006-12-29 |
2008-07-10 |
Rigel Pharmaceuticals, Inc. |
Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
|
PL2078010T3
(pl)
|
2006-12-29 |
2014-07-31 |
Rigel Pharmaceuticals Inc |
Triazole podstawione policyklicznym heteroarylem użyteczne jako inhibitory Axl
|
EP1944369A1
(en)
|
2007-01-12 |
2008-07-16 |
The Centre National de la Recherche Scientifique |
Dbait and its standalone uses thereof
|
US8168415B2
(en)
|
2007-02-07 |
2012-05-01 |
The Regents Of The University Of Colorado |
Axl fusion proteins as Axl tyrosine kinase inhibitors
|
AU2008217931A1
(en)
|
2007-02-23 |
2008-08-28 |
Eisai R & D Management Co., Ltd. |
Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of HGFR gene
|
CN101622015A
(zh)
|
2007-03-05 |
2010-01-06 |
协和发酵麒麟株式会社 |
药物组合物
|
WO2008109943A1
(en)
|
2007-03-12 |
2008-09-18 |
Cytopia Research Pty Ltd |
Phenyl amino pyrimidine compounds and uses thereof
|
KR20090129488A
(ko)
|
2007-03-22 |
2009-12-16 |
버텍스 파마슈티칼스 인코포레이티드 |
야누스 키나아제의 억제제로서 유용한 n-헤테로사이클릭 화합물
|
BRPI0810086B1
(pt)
|
2007-03-28 |
2021-11-09 |
Pharmacyclics Llc |
Composto inibidor de tirosina quinase de bruton, uso do referido composto e composição farmacêutica
|
US7998966B2
(en)
|
2007-04-13 |
2011-08-16 |
Supergen, Inc. |
Axl kinase inhibitors
|
UA99459C2
(en)
|
2007-05-04 |
2012-08-27 |
Астразенека Аб |
9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
GB0714384D0
(en)
|
2007-07-23 |
2007-09-05 |
Ucb Pharma Sa |
theraputic agents
|
AP2817A
(en)
|
2007-07-30 |
2013-12-31 |
Ardea Biosciences Inc |
Derivatives of n-(arylamino)sulfonamides includingpolymorphs as inhibitors of mek as well as compos itions, methods of use and methods for preparing the same
|
CA2924436A1
(en)
|
2007-07-30 |
2009-02-05 |
Ardea Biosciences, Inc. |
Pharmaceutical combinations of n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide as inhibitors of mek and methods of use
|
PA8792501A1
(es)
|
2007-08-09 |
2009-04-23 |
Sanofi Aventis |
Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol,su procedimiento de preparación,su aplicación como medicamentos,composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met.
|
BRPI0816278A2
(pt)
|
2007-09-05 |
2015-09-22 |
Pfizer Ltd |
forma sal
|
JP5587193B2
(ja)
|
2007-10-23 |
2014-09-10 |
エフ.ホフマン−ラ ロシュ アーゲー |
新規なキナーゼ阻害剤
|
US8304547B2
(en)
|
2007-10-24 |
2012-11-06 |
Astellas Pharma Inc. |
Azolecarboxamide compound or salt thereof
|
JP5635909B2
(ja)
|
2007-10-26 |
2014-12-03 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Axl阻害剤として有用な多環アリール置換トリアゾール及び多環ヘテロアリール置換トリアゾール
|
PL2215094T3
(pl)
|
2007-11-15 |
2016-09-30 |
|
Związki heterocykliczne zawierające n
|
US20110039856A1
(en)
|
2007-11-29 |
2011-02-17 |
Pfizer Inc. |
Polymorphs of a c-met/hgfr inhibitor
|
EP2240494B1
(en)
|
2008-01-21 |
2016-03-30 |
UCB Biopharma SPRL |
Thieno-pyridine derivatives as mek inhibitors
|
GB0801416D0
(en)
|
2008-01-25 |
2008-03-05 |
Piramed Ltd |
Pharmaceutical compounds
|
EP2252597B1
(en)
|
2008-02-01 |
2014-03-19 |
Akinion Pharmaceuticals AB |
Pyrazine derivatives and their use as protein kinase inhibitors
|
KR101308803B1
(ko)
|
2008-02-05 |
2013-09-13 |
에프. 호프만-라 로슈 아게 |
신규한 피리디논 및 피리다지논
|
JP5230755B2
(ja)
|
2008-02-22 |
2013-07-10 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
c−kitおよびPDGFRキナーゼ阻害剤としてのヘテロ環化合物および組成物
|
EP2265609B1
(en)
|
2008-02-29 |
2012-09-05 |
Array Biopharma, Inc. |
Imdizo [4. 5-b] pyridine derivatives used as raf inhibitors
|
AU2009222143A1
(en)
|
2008-02-29 |
2009-09-11 |
Array Biopharma Inc. |
Raf inhibitor compounds and methods of use thereof
|
ES2400202T3
(es)
|
2008-02-29 |
2013-04-08 |
Array Biopharma, Inc. |
Inhibidores de RAF de pirazol[3,4-B]piridina
|
CA2716949A1
(en)
|
2008-02-29 |
2009-09-11 |
Array Biopharma Inc. |
N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
|
ES2602577T3
(es)
|
2008-03-11 |
2017-02-21 |
Incyte Holdings Corporation |
Derivados de azetidina y ciclobutano como inhibidores de JAK
|
MX2010010272A
(es)
|
2008-03-19 |
2011-05-25 |
Chembridge Corp |
Nuevos inhibidores de tirosina quinasa.
|
CA2721183C
(en)
|
2008-04-11 |
2019-07-16 |
Alnylam Pharmaceuticals, Inc. |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
JP2011518786A
(ja)
|
2008-04-14 |
2011-06-30 |
アルデア バイオサイエンシズ,インコーポレイティド |
調製及び使用のための組成物及び方法
|
WO2009127417A1
(en)
|
2008-04-16 |
2009-10-22 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Quinoline derivatives as axl kinase inhibitors
|
EP2323993B1
(en)
|
2008-04-16 |
2015-06-03 |
Portola Pharmaceuticals, Inc. |
2,6-diamino- pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
|
CN102066340B
(zh)
|
2008-04-16 |
2014-05-14 |
波托拉医药品公司 |
作为syk或jak蛋白激酶抑制剂的2,6-二氨基-嘧啶-5-基甲酰胺类化合物
|
CA2723185A1
(en)
|
2008-04-22 |
2009-10-29 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
JP2011518836A
(ja)
|
2008-04-24 |
2011-06-30 |
インサイト・コーポレイション |
大環状化合物およびそれらのキナーゼ阻害剤としての使用
|
CN103936743B
(zh)
|
2008-05-21 |
2018-04-24 |
因西特控股公司 |
2-氟-N-甲基-4-[7-(喹啉-6-基甲基)咪唑并[1,2-b][1,2,4]三嗪-2-基]苯甲酰胺的盐及与其相关的制备方法
|
JP2011523646A
(ja)
|
2008-05-21 |
2011-08-18 |
アリアド・ファーマシューティカルズ・インコーポレイテッド |
キナーゼ阻害剤としてのリン誘導体
|
WO2009153592A1
(en)
|
2008-06-19 |
2009-12-23 |
Astrazeneca Ab |
Pyrazole compounds 436
|
GB0811304D0
(en)
|
2008-06-19 |
2008-07-30 |
Ucb Pharma Sa |
Therapeutic agents
|
EP2296475A4
(en)
|
2008-06-20 |
2014-03-05 |
Genentech Inc |
TRIAZOLOPYRIDINE COMPOUNDS JAK KINASE INHIBITORS AND METHODS
|
BRPI0910021A2
(pt)
|
2008-06-20 |
2015-09-01 |
Genentech Inc |
"composto, composição farmacêutica, método para tratar ou atenuar a gravidade de uma doença ou condição responsiva à inibição da atividade jak2 quinas em um paciente, kit para o tratamento de uma doença ou distúrbio responsivo à inibição da jak quinase"
|
BRPI0914657A2
(pt)
|
2008-06-24 |
2019-09-24 |
F Hoffmann La Roche |
piridin-2-onae piridazin-3-onas substituídas
|
ES2537480T3
(es)
|
2008-07-09 |
2015-06-08 |
Rigel Pharmaceuticals, Inc. |
Triazoles sustituidos con heteroarilo policíclicos útiles como inhibidores de Axl
|
PL2328888T3
(pl)
|
2008-07-09 |
2013-04-30 |
Rigel Pharmaceuticals Inc |
Triazole podstawione mostkowanym bicyklicznym heteroarylem użyteczne jako inhibitory AXL
|
CA2730930C
(en)
|
2008-07-16 |
2015-01-13 |
Pharmacyclics, Inc. |
Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
|
EP2310366A2
(fr)
|
2008-07-18 |
2011-04-20 |
Sanofi-Aventis |
NOUVEAUX DERIVES TRIAZOLO(4,3-a)PYRIDINE,LEUR PROCEDE DE PREPARATION,LEUR APPLICATION A TITRE DE MEDICAMENTS,COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE MET
|
CN102159559A
(zh)
|
2008-07-18 |
2011-08-17 |
赛诺菲-安万特 |
新型咪唑并[1,2-a]吡啶衍生物、其制备方法、其作为药物的用途、其药物组合物和新型用途特别是作为MET抑制剂的新型用途
|
FR2933982A1
(fr)
|
2008-07-18 |
2010-01-22 |
Sanofi Aventis |
Nouveaux derives imidazo°1,2-a!pyrimidine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met
|
BRPI0916566B8
(pt)
|
2008-08-04 |
2021-05-25 |
Merck Patent Ges Mit Beschraenkter Haftung |
isonicotinamida fenilamina, seu uso, composição farmacêutica, e kit
|
UY32049A
(es)
|
2008-08-14 |
2010-03-26 |
Takeda Pharmaceutical |
Inhibidores de cmet
|
CN103965200B
(zh)
|
2008-09-22 |
2016-06-08 |
阵列生物制药公司 |
作为trk激酶抑制剂的取代的咪唑并[1,2-b]哒嗪化合物
|
SI2725028T1
(sl)
|
2008-10-22 |
2016-10-28 |
Array Biopharma, Inc. |
Substituirane spojine pirazolo(1,5-)pirimidina kot vmesne spojine v sintezi inhibitorjev TRK kinaze
|
WO2010051549A1
(en)
|
2008-10-31 |
2010-05-06 |
Genentech, Inc. |
Pyrazolopyrimidine jak inhibitor compounds and methods
|
EP2365970B1
(en)
|
2008-11-12 |
2018-03-21 |
Gilead Connecticut, Inc. |
Pyridazinones and their use as btk inhibitors
|
KR20110094285A
(ko)
|
2008-11-19 |
2011-08-23 |
버텍스 파마슈티칼스 인코포레이티드 |
c-Met 단백질 키나제의 트리아졸로티아디아졸 억제제
|
CA2745871C
(en)
|
2008-12-08 |
2018-02-20 |
Gilead Connecticut, Inc. |
Imidazopyrazine syk inhibitors
|
DK2716157T3
(en)
|
2008-12-08 |
2016-08-15 |
Gilead Connecticut Inc |
Imidazopyrazin-Syk inhibitors
|
ITMI20082336A1
(it)
|
2008-12-29 |
2010-06-30 |
Univ Parma |
Composti inibitori irreversibili di egfr con attivita' antiproliferativa
|
EP2376481B1
(en)
|
2009-01-13 |
2013-08-07 |
Glaxo Group Limited |
Pyrimidinecarboxamide derivatives as inhibitors of syk kinase
|
JOP20190230A1
(ar)
|
2009-01-15 |
2017-06-16 |
Incyte Corp |
طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
|
RU2555326C2
(ru)
|
2009-01-16 |
2015-07-10 |
Риджел Фармасьютикалз, Инк. |
ИНГИБИТОРЫ Axl ДЛЯ ПРИМЕНЕНИЯ В КОМБИНИРОВАННОЙ ТЕРАПИИ ДЛЯ ПРЕДОТВРАЩЕНИЯ, УСТРАНЕНИЯ ИЛИ ЛЕЧЕНИЯ МЕТАСТAЗИРУЮЩЕГО РАКА
|
US8765727B2
(en)
|
2009-01-23 |
2014-07-01 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
FR2941951B1
(fr)
|
2009-02-06 |
2011-04-01 |
Sanofi Aventis |
Derives de 6-(6-nh-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
|
FR2941952B1
(fr)
|
2009-02-06 |
2011-04-01 |
Sanofi Aventis |
Derives de 6-(6-substitue-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles et 5-fluoro-benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
|
JP2012517426A
(ja)
|
2009-02-09 |
2012-08-02 |
アステックス ファーマシューティカルズ インコーポレイテッド |
ピロロピリミジニルaxlキナーゼ阻害剤
|
WO2010108652A1
(en)
|
2009-03-27 |
2010-09-30 |
Ardea Biosciences Inc. |
Dihydropyridin sulfonamides and dihydropyridin sulfamides as mek inhibitors
|
WO2010121646A1
(en)
|
2009-04-21 |
2010-10-28 |
Novartis Ag |
Heterocyclic compounds as mek inhibitors
|
WO2010126960A1
(en)
|
2009-04-29 |
2010-11-04 |
Locus Pharmaceuticals, Inc. |
Pyrrolotriazine compounds
|
WO2010129053A2
(en)
|
2009-05-05 |
2010-11-11 |
Dana Farber Cancer Institute |
Egfr inhibitors and methods of treating disorders
|
NZ596374A
(en)
|
2009-05-22 |
2014-01-31 |
Incyte Corp |
3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
|
ES2575084T3
(es)
|
2009-06-10 |
2016-06-24 |
Chugai Seiyaku Kabushiki Kaisha |
Compuesto tetracíclico
|
TW201103904A
(en)
|
2009-06-11 |
2011-02-01 |
Hoffmann La Roche |
Janus kinase inhibitor compounds and methods
|
CN102134218A
(zh)
|
2009-06-15 |
2011-07-27 |
凯美隆(北京)药业技术有限公司 |
6-芳氨基吡啶酮磺酰胺和6-芳氨基吡嗪酮磺酰胺mek抑制剂
|
JP5744859B2
(ja)
|
2009-06-15 |
2015-07-08 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
脾臓チロシンキナーゼ(syk)の小分子阻害薬
|
TWI462920B
(zh)
|
2009-06-26 |
2014-12-01 |
葛萊伯格有限公司 |
用於治療退化性及發炎疾病之新穎化合物
|
UA110324C2
(en)
|
2009-07-02 |
2015-12-25 |
Genentech Inc |
Jak inhibitory compounds based on pyrazolo pyrimidine
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
TW201105669A
(en)
|
2009-07-30 |
2011-02-16 |
Irm Llc |
Compounds and compositions as Syk kinase inhibitors
|
JP2013501002A
(ja)
|
2009-07-30 |
2013-01-10 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Sykキナーゼ阻害剤としての化合物および組成物
|
JP2013503193A
(ja)
|
2009-08-28 |
2013-01-31 |
ジェネンテック, インコーポレイテッド |
Raf阻害剤化合物およびその使用方法
|
CA2772316A1
(en)
|
2009-08-28 |
2011-03-03 |
Array Biopharma Inc. |
1h-pyrazolo [3,4-b] pyridine compounds for inhibiting raf kinase
|
CA2771895A1
(en)
|
2009-08-28 |
2011-03-03 |
Array Biopharma Inc. |
Raf inhibitor compounds and methods of use thereof
|
US20130018033A1
(en)
|
2009-08-28 |
2013-01-17 |
Array Biopharma Inc. |
Raf inhibitor compounds and methods of use thereof
|
EP2485589A4
(en)
|
2009-09-04 |
2013-02-06 |
Biogen Idec Inc |
HETEROARYARY INHIBITORS OF BTK
|
EP2473049B1
(en)
|
2009-09-04 |
2018-11-28 |
Biogen MA Inc. |
Bruton's tyrosine kinase inhibitors
|
WO2011039527A1
(en)
|
2009-09-30 |
2011-04-07 |
Merck Sharp & Dohme Ltd |
Formulations for c-met kinase inhibitors
|
BR112012008599A2
(pt)
|
2009-10-13 |
2019-09-24 |
Allostem Therapeutics Llc |
composto da formula (i), composto da fórmula (ia), composto da fórmula (ic), composto da fórmula (ii), composto da fórmula (iia), composto, método para tratamento de um transtorno hiperproliferativo em um mamífero, que inclui um humano, método para tratamento de uma doença, condição ou transtorno inflamatório em um mamífero, que inclui um humano, método para tratamento de um transtorno ou condição que é modulada pela cascata de meik em um mamífero, que inclui um himano, método para tratar ou prevenir câncer, composição farmacêutica e método para inibir uma enzima mek
|
PL3560498T3
(pl)
|
2009-10-16 |
2022-12-12 |
Novartis Ag |
Kombinacja zawierająca inhibitor mek i inhibitor b-raf
|
AU2010317167B2
(en)
|
2009-11-04 |
2012-11-29 |
Novartis Ag |
Heterocyclic sulfonamide derivatives useful as MEK inhibitors
|
MX2012007154A
(es)
|
2009-12-17 |
2012-08-01 |
Merck Sharp & Dohme |
Aminopirimidinas como inhibidores de syk.
|
US8735417B2
(en)
|
2009-12-17 |
2014-05-27 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as Syk inhibitors
|
MX2012007402A
(es)
|
2009-12-23 |
2012-08-23 |
Takeda Pharmaceutical |
Pirrolidinonas heteroaromaticas fusionadas como inhibidores de tirosina cinasa esplenica (syk).
|
MY156701A
(en)
|
2009-12-23 |
2016-03-15 |
Arqule Inc |
Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
|
EP2338888A1
(en)
|
2009-12-24 |
2011-06-29 |
Almirall, S.A. |
Imidazopyridine derivatives as JAK inhibitors
|
AU2010343102B2
(en)
|
2009-12-29 |
2016-03-24 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
NZ601143A
(en)
|
2010-01-12 |
2014-10-31 |
Ab Science |
Thiazole and oxazole kinase inhibitors
|
CA2786245A1
(en)
|
2010-01-29 |
2011-08-04 |
Boehringer Ingelheim International Gmbh |
Substituted naphthyridines and their use as syk kinase inhibitors
|
AU2011226689B2
(en)
|
2010-03-11 |
2016-09-01 |
Kronos Bio, Inc. |
Imidazopyridines Syk inhibitors
|
US8481541B2
(en)
|
2010-03-22 |
2013-07-09 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
EP2550266B1
(en)
|
2010-03-24 |
2018-05-09 |
Amitech Therapeutics Solutions, Inc. |
Heterocyclic compounds useful for kinase inhibition
|
WO2011121223A1
(fr)
|
2010-03-30 |
2011-10-06 |
Sanofi-Aventis |
Derives de 6-(alkyl- ou cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles: preparation, application comme medicaments et utilisation comme inhibiteurs de met
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
WO2011138751A2
(en)
|
2010-05-04 |
2011-11-10 |
Pfizer Inc. |
Heterocyclic derivatives as alk inhibitors
|
JP2013526570A
(ja)
|
2010-05-14 |
2013-06-24 |
オーエスアイ・ファーマシューティカルズ,エルエルシー |
縮合二環式キナーゼ阻害剤
|
RU2012152354A
(ru)
|
2010-05-20 |
2014-06-27 |
Ф. Хоффманн-Ля Рош Аг |
Производные пирролопиразина в качестве ингибиторов syk и jak
|
BR112012029437A2
(pt)
|
2010-05-20 |
2017-03-07 |
F Hoffmann - La Roche Ag |
derivados de pirrolo[2,3-b]pirazina-7-carboxamida e seu uso como inibidores de jak e syk
|
WO2011149878A1
(en)
|
2010-05-27 |
2011-12-01 |
Vertex Pharmaceuticals Incorporated |
An aminopyrazole triazolothiadiazole inhibitor of c-met protein kinase
|
US8669256B2
(en)
|
2010-05-28 |
2014-03-11 |
Merck Sharp & Dohme B.V. |
Substituted thieno[2,3-b]pyrazine compounds as modulators of B-Raf kinase activity
|
ES2592152T3
(es)
|
2010-05-31 |
2016-11-28 |
Ono Pharmaceutical Co., Ltd. |
Derivado de purinona como inhibidor de Btk quinasa
|
SG186077A1
(en)
|
2010-06-03 |
2013-01-30 |
Pharmacyclics Inc |
The use of inhibitors of bruton's tyrosine kinase (btk)
|
CN104788523B
(zh)
|
2010-06-22 |
2017-09-08 |
欧恩科斯欧公司 |
用于核酸结合物的具有内涵体溶解剂的优化的体内递送系统
|
JP5744021B2
(ja)
|
2010-06-30 |
2015-07-01 |
富士フイルム株式会社 |
新規なニコチンアミド誘導体またはその塩
|
WO2012005299A1
(ja)
|
2010-07-07 |
2012-01-12 |
日本新薬株式会社 |
Rosチロシンキナーゼ阻害剤
|
AU2011278832B2
(en)
|
2010-07-14 |
2014-03-13 |
Betta Pharmaceuticals Co., Ltd |
Novel fused heterocyclic derivatives useful as c-Met tyrosine kinase inhibitors
|
JP5789259B2
(ja)
|
2010-07-16 |
2015-10-07 |
協和発酵キリン株式会社 |
含窒素芳香族複素環誘導体
|
WO2012008564A1
(ja)
|
2010-07-16 |
2012-01-19 |
協和発酵キリン株式会社 |
含窒素芳香族複素環誘導体
|
AR085183A1
(es)
|
2010-07-30 |
2013-09-18 |
Lilly Co Eli |
Compuesto 6-(1-metil-1h-pirazol-4-il)-3-(2-metil-2h-indazol-5-iltio)-[1,2,4]triazol[4,3-b]piridazina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar cancer
|
TW201219383A
(en)
|
2010-08-02 |
2012-05-16 |
Astrazeneca Ab |
Chemical compounds
|
WO2012021444A1
(en)
|
2010-08-10 |
2012-02-16 |
Avila Therapeutics, Inc. |
Besylate salt of a btk inhibitor
|
TWI526441B
(zh)
|
2010-08-20 |
2016-03-21 |
中外製藥股份有限公司 |
包含四環化合物的組成物
|
CA2809331C
(en)
|
2010-08-27 |
2018-09-25 |
Merck Patent Gmbh |
Triazolopyrazine derivatives
|
AU2011295441B2
(en)
|
2010-08-27 |
2015-04-09 |
Merck Patent Gmbh |
Furopyridine derivatives
|
EP2423208A1
(en)
|
2010-08-28 |
2012-02-29 |
Lead Discovery Center GmbH |
Pharmaceutically active compounds as Axl inhibitors
|
US8637516B2
(en)
|
2010-09-09 |
2014-01-28 |
Irm Llc |
Compounds and compositions as TRK inhibitors
|
US8664244B2
(en)
|
2010-09-12 |
2014-03-04 |
Advenchen Pharmaceuticals, LLC |
Compounds as c-Met kinase inhibitors
|
WO2012037155A2
(en)
|
2010-09-13 |
2012-03-22 |
Gtx, Inc. |
Tyrosine kinase inhibitors
|
JO3062B1
(ar)
|
2010-10-05 |
2017-03-15 |
Lilly Co Eli |
R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري
|
WO2012048258A2
(en)
|
2010-10-08 |
2012-04-12 |
Xcovery Holding Company, Llc |
Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
|
CN103282352B
(zh)
|
2010-11-01 |
2016-08-10 |
波托拉医药品公司 |
作为syk调节剂的苯甲酰胺类和烟酰胺类
|
CN102020651B
(zh)
|
2010-11-02 |
2012-07-18 |
北京赛林泰医药技术有限公司 |
6-芳基氨基吡啶酮甲酰胺mek抑制剂
|
CN102532141A
(zh)
|
2010-12-08 |
2012-07-04 |
中国科学院上海药物研究所 |
[1,2,4]三唑并[4,3-b][1,2,4]三嗪类化合物、其制备方法和用途
|
US20130004481A1
(en)
|
2011-01-12 |
2013-01-03 |
Boehringer Ingelheim International Gmbh |
Anticancer therapy
|
CA2828219A1
(en)
|
2011-02-25 |
2012-08-30 |
Irm Llc |
Pyrazolo [1,5-a] pyridines as trk inhibitors
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
JP2014507458A
(ja)
|
2011-03-11 |
2014-03-27 |
グラクソ グループ リミテッド |
Sykインヒビターとしてのピリド[3,4−B]ピラジン誘導体
|
MX342310B
(es)
|
2011-03-28 |
2016-09-26 |
Hoffmann La Roche |
Compuestos de tiazolopirimidina.
|
ES2759615T3
(es)
|
2011-04-01 |
2020-05-11 |
Univ Utah Res Found |
Análogos de N-fenilpirimidina-2-amina sustituidos como inhibidores de la quinasa AXL
|
WO2012135801A1
(en)
|
2011-04-01 |
2012-10-04 |
University Of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
CN103534257A
(zh)
|
2011-04-05 |
2014-01-22 |
辉瑞有限公司 |
作为原肌球蛋白相关激酶抑制剂的吡咯并[2,3-d]嘧啶衍生物
|
US8796310B2
(en)
|
2011-05-04 |
2014-08-05 |
Merck Sharp & Dohme Corp. |
Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitors
|
US9145391B2
(en)
|
2011-05-10 |
2015-09-29 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as Syk inhibitors
|
RU2013154412A
(ru)
|
2011-05-10 |
2015-06-20 |
Мерк Шарп И Доум Корп. |
Аминопиримидины в качестве ингибиторов syc
|
WO2012154520A1
(en)
|
2011-05-10 |
2012-11-15 |
Merck Sharp & Dohme Corp. |
Pyridyl aminopyridines as syk inhibitors
|
PT2712358T
(pt)
|
2011-05-13 |
2017-02-20 |
Array Biopharma Inc |
Compostos de pirrolidinil ureia, pirrolidinil tioureia e pirrolidinil guanida como inibidores de trka quinase
|
EP2527440A1
(en)
*
|
2011-05-27 |
2012-11-28 |
Institut Curie |
Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
|
WO2012167423A1
(en)
|
2011-06-08 |
2012-12-13 |
Hutchison Medipharma Limited |
Substituted pyridopyrazines as novel syk inhibitors
|
CN102816162B
(zh)
|
2011-06-10 |
2016-04-27 |
中国科学院广州生物医药与健康研究院 |
嘧啶并嘧啶酮类化合物及其药用组合物和应用
|
HUE059230T2
(hu)
|
2011-06-10 |
2022-10-28 |
Merck Patent Gmbh |
Vegyületek és eljárások BTK-inhibitor aktivitású pirimidin és piridin vegyületek elõállítására
|
CN102393896B
(zh)
|
2011-07-11 |
2014-08-27 |
成都西谷曙光数字技术有限公司 |
一种简单精确的射频定位系统和方法
|
EP2731439A4
(en)
|
2011-07-12 |
2014-12-03 |
Merck Sharp & Dohme |
TrkA KINASE INHIBITORS, COMPOSITIONS CONTAINING SAME, AND ASSOCIATED METHODS
|
PE20141681A1
(es)
|
2011-07-19 |
2014-11-14 |
Merck Sharp And Dohme B V |
Inhibidores de btk
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
EP2734523A1
(en)
|
2011-07-19 |
2014-05-28 |
Merck Sharp & Dohme B.V. |
4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides btk-inhibitors
|
CA2840029C
(en)
|
2011-07-27 |
2021-07-20 |
Ab Science |
Oxazole and thiazole derivatives as selective protein kinase inhibitors (c-kit)
|
CA2842841C
(en)
|
2011-07-27 |
2016-04-19 |
Nanjing Allgen Pharma Co. Ltd. |
Spirocyclic molecules as protein kinase inhibitors
|
AU2012302080A1
(en)
|
2011-09-01 |
2014-04-17 |
Irm Llc |
Compounds and compositions as c-kit kinase inhibitors
|
US9199981B2
(en)
|
2011-09-01 |
2015-12-01 |
Novartis Ag |
Compounds and compositions as C-kit kinase inhibitors
|
BR112014004319A2
(pt)
|
2011-09-01 |
2017-03-14 |
Irm Llc |
compostos e composições como inibidores de c-kit cinase
|
WO2013033167A1
(en)
|
2011-09-01 |
2013-03-07 |
Irm Llc |
Compounds and compositions as c-kit kinase inhibitors
|
AU2012308238B2
(en)
|
2011-09-14 |
2017-05-25 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
US9145414B2
(en)
|
2011-09-30 |
2015-09-29 |
Taiho Pharmaceutical Co., Ltd. |
1,2,4-triazine-6-carboxamide derivative
|
EP2763975B1
(en)
|
2011-10-05 |
2016-04-06 |
Merck Sharp & Dohme Corp. |
3-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
US9006444B2
(en)
|
2011-10-05 |
2015-04-14 |
Merck Sharp & Dohme Corp. |
Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
|
WO2013052394A1
(en)
|
2011-10-05 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
UA111382C2
(uk)
|
2011-10-10 |
2016-04-25 |
Оріон Корпорейшн |
Інгібітори протеїнкінази
|
CN110801454A
(zh)
|
2011-10-19 |
2020-02-18 |
药品循环有限责任公司 |
布鲁顿酪氨酸激酶(btk)抑制剂的用途
|
JP6173327B2
(ja)
|
2011-11-01 |
2017-08-02 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
イミダゾピリダジン化合物
|
IN2014CN03265A
(US07655688-20100202-C00086.png)
|
2011-11-03 |
2015-07-03 |
Hoffmann La Roche |
|
CN104203937A
(zh)
|
2011-11-03 |
2014-12-10 |
霍夫曼-拉罗奇有限公司 |
作为btk活性的抑制剂的8-氟酞嗪-1(2h)-酮化合物
|
UA111756C2
(uk)
|
2011-11-03 |
2016-06-10 |
Ф. Хоффманн-Ля Рош Аг |
Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
|
CN103958497B
(zh)
|
2011-11-14 |
2017-09-01 |
亚尼塔公司 |
作为AXL和c‑MET激酶抑制剂的尿嘧啶衍生物
|
WO2013081016A1
(ja)
|
2011-11-29 |
2013-06-06 |
小野薬品工業株式会社 |
プリノン誘導体塩酸塩
|
DK2791138T3
(en)
|
2011-12-12 |
2018-09-17 |
Dr Reddys Laboratories Ltd |
Substituted pyrazole [1,5-a] pyridines as tropomyosin receptor kinase (TRK) inhibitors.
|
KR102032934B1
(ko)
|
2011-12-21 |
2019-10-16 |
지앙수 헨그루이 메디슨 컴퍼니 리미티드 |
피롤 6원 헤테로아릴 고리 유도체, 그의 제조 방법, 및 그의 의약 용도
|
WO2013099041A1
(ja)
|
2011-12-28 |
2013-07-04 |
富士フイルム株式会社 |
新規なニコチンアミド誘導体またはその塩
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
CA2860548A1
(en)
|
2012-01-10 |
2013-07-18 |
Shaoqing Chen |
Thienopyrimidine compounds
|
EP2802567B1
(en)
|
2012-01-10 |
2017-03-01 |
F. Hoffmann-La Roche AG |
Pyridazine amide compounds and their use as syk inhibitors
|
CN103204844A
(zh)
|
2012-01-17 |
2013-07-17 |
上海艾力斯医药科技有限公司 |
氨基杂芳基化合物及其制备方法与应用
|
CN103204827B
(zh)
|
2012-01-17 |
2014-12-03 |
上海科州药物研发有限公司 |
作为蛋白激酶抑制剂的苯并噻二唑化合物及其制备方法和用途
|
MX351513B
(es)
|
2012-01-19 |
2017-10-17 |
Taiho Pharmaceutical Co Ltd |
Compuesto de alquinilbenceno 3,5-disustituido y sales del mismo.
|
AU2013209586B2
(en)
|
2012-01-20 |
2017-08-17 |
Genosco |
Substituted pyrimidine compounds and their use as SYK inhibitors
|
US8501724B1
(en)
|
2012-01-31 |
2013-08-06 |
Pharmacyclics, Inc. |
Purinone compounds as kinase inhibitors
|
TWI537259B
(zh)
|
2012-01-31 |
2016-06-11 |
第一三共股份有限公司 |
吡啶酮衍生物
|
ES2674451T3
(es)
|
2012-02-21 |
2018-06-29 |
Merck Patent Gmbh |
2-amino-[1,2,4]triazolo[1,5-a] pirazinas 8-sustituidos como inhibidores de la SYK tirosina quinasa e inhibidores de la serina quinasa GCN2
|
WO2013124025A1
(en)
|
2012-02-21 |
2013-08-29 |
Merck Patent Gmbh |
Furopyridine derivatives
|
CA2865040C
(en)
|
2012-02-21 |
2020-07-14 |
Merck Patent Gmbh |
Cyclic diaminopyrimidine derivatives
|
WO2013124869A2
(en)
|
2012-02-21 |
2013-08-29 |
Amrita Vishwa Vidyapeetham University |
The art, method,manner process and system of fibrous bio-degradable polymeric wafers for the local delivery of therapeutic agents in combinations
|
TWI542581B
(zh)
|
2012-02-28 |
2016-07-21 |
Astellas Pharma Inc |
Containing aromatic aromatic heterocyclic compounds
|
CN107698585A
(zh)
|
2012-03-14 |
2018-02-16 |
鲁宾有限公司 |
杂环基化合物
|
EP2825041B1
(en)
|
2012-03-15 |
2021-04-21 |
Celgene CAR LLC |
Solid forms of an epidermal growth factor receptor kinase inhibitor
|
NZ700283A
(en)
|
2012-03-22 |
2016-08-26 |
Oscotec Inc |
Substituted pyridopyrimidine compounds and their use as flt3 inhibitors
|
US9365566B2
(en)
|
2012-03-27 |
2016-06-14 |
Takeda Pharmaceutical Company Limited |
Cinnoline derivatives
|
MX354783B
(es)
|
2012-03-30 |
2018-03-21 |
Novartis Ag |
Inhibidor de fgfr para su uso en el tratamiento de trastornos hipofosfatemicos.
|
WO2013149581A1
(en)
|
2012-04-03 |
2013-10-10 |
Novartis Ag |
Combination products with tyrosine kinase inhibitors and their use
|
EP2833886B1
(en)
|
2012-04-04 |
2020-08-12 |
HangzhouDeRenYuCheng Biotechnology Ltd. |
Substituted quinolines as bruton's tyrosine kinase inhibitors
|
WO2013157540A1
(ja)
|
2012-04-17 |
2013-10-24 |
富士フイルム株式会社 |
含窒素複素環化合物またはその塩
|
DK2838998T3
(en)
|
2012-04-18 |
2018-01-15 |
Cell Signaling Technology Inc |
EGFR AND ROS1 IN CANCER
|
EP2842955B1
(en)
|
2012-04-26 |
2016-10-05 |
ONO Pharmaceutical Co., Ltd. |
Trk-inhibiting compound
|
CN106008511B
(zh)
|
2012-05-14 |
2018-08-14 |
华东理工大学 |
蝶啶酮衍生物及其作为egfr、blk、flt3抑制剂的应用
|
WO2013176970A1
(en)
|
2012-05-22 |
2013-11-28 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
WO2013180183A1
(ja)
|
2012-05-30 |
2013-12-05 |
日本新薬株式会社 |
芳香族複素環誘導体及び医薬
|
GB201209613D0
(en)
|
2012-05-30 |
2012-07-11 |
Astex Therapeutics Ltd |
New compounds
|
TWI585088B
(zh)
|
2012-06-04 |
2017-06-01 |
第一三共股份有限公司 |
作爲激酶抑制劑之咪唑并[1,2-b]嗒衍生物
|
AR091273A1
(es)
|
2012-06-08 |
2015-01-21 |
Biogen Idec Inc |
Inhibidores de pirimidinil tirosina quinasa
|
WO2014007951A2
(en)
|
2012-06-13 |
2014-01-09 |
Incyte Corporation |
Substituted tricyclic compounds as fgfr inhibitors
|
BR112014030651A2
(pt)
|
2012-06-14 |
2017-06-27 |
Lilly Co Eli |
inibidor de jak1 e jak2
|
US9242984B2
(en)
|
2012-06-20 |
2016-01-26 |
Merck Sharp & Dohme Corp. |
Pyrazolyl derivatives as Syk inhibitors
|
WO2013192128A1
(en)
|
2012-06-20 |
2013-12-27 |
Merck Sharp & Dohme Corp. |
Imidazolyl analogs as syk inhibitors
|
US9376418B2
(en)
|
2012-06-22 |
2016-06-28 |
Merck Sharp & Dohme Corp. |
Substituted pyridine spleen tyrosine kinase (SYK) inhibitors
|
EP2863915B1
(en)
|
2012-06-22 |
2017-12-06 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
TWI520962B
(zh)
|
2012-06-29 |
2016-02-11 |
|
As the c-Met tyrosine kinase inhibitors novel fused pyridine derivatives
|
CA2782774A1
(en)
|
2012-07-06 |
2014-01-06 |
Pharmascience Inc. |
Protein kinase inhibitors
|
WO2014009319A1
(en)
|
2012-07-11 |
2014-01-16 |
Boehringer Ingelheim International Gmbh |
Indolinone derivatives anticancer compounds
|
CA2881279C
(en)
|
2012-08-07 |
2020-07-07 |
Merck Patent Gmbh |
Pyridopyrimidine derivatives as protein kinase inhibitors
|
IN2015DN00524A
(US07655688-20100202-C00086.png)
|
2012-08-10 |
2015-06-26 |
Boehringer Ingelheim Int |
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
BR112015003058A2
(pt)
|
2012-08-13 |
2017-07-04 |
Novartis Ag |
derivados bicíclicos de heteroaril cicloalquildiamina como inibidores de tirosina quinases do baço (syk)
|
WO2014031438A2
(en)
|
2012-08-20 |
2014-02-27 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED PHENYL SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
EP2888262B1
(en)
|
2012-08-21 |
2018-12-19 |
F.Hoffmann-La Roche Ag |
Pyrrolo[2,3-b]pyrazines as syk inhibitors
|
CN103122000B
(zh)
|
2012-09-03 |
2013-12-25 |
中美冠科生物技术(太仓)有限公司 |
用作抗肿瘤药物的高选择性的c-Met激酶抑制剂
|
NZ630925A
(en)
|
2012-09-10 |
2016-10-28 |
Principia Biopharma Inc |
Pyrazolopyrimidine compounds as kinase inhibitors
|
US9533989B2
(en)
|
2012-09-18 |
2017-01-03 |
Ziarco Pharma Ltd. |
Substituted pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitors
|
HUE040055T2
(hu)
|
2012-09-25 |
2019-02-28 |
Chugai Pharmaceutical Co Ltd |
RET inhibitor
|
WO2014051654A2
(en)
|
2012-09-27 |
2014-04-03 |
Portola Pharmaceuticals, Inc. |
Bicyclic oxa-lactam kinase inhibitors
|
WO2014048065A1
(en)
|
2012-09-28 |
2014-04-03 |
Merck Sharp & Dohme Corp. |
Triazolyl derivatives as syk inhibitors
|
US9296703B2
(en)
|
2012-10-04 |
2016-03-29 |
University Of Utah Research Foundation |
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors
|
WO2014055928A2
(en)
|
2012-10-04 |
2014-04-10 |
University Of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
CN104955805B
(zh)
|
2012-10-19 |
2018-11-09 |
霍夫曼-拉罗奇有限公司 |
Syk的抑制剂
|
KR20150074007A
(ko)
|
2012-10-26 |
2015-07-01 |
에프. 호프만-라 로슈 아게 |
3,4-이치환된 1h-피라졸 및 4,5-이치환된 티아졸 syk 억제제
|
US20150291554A1
(en)
|
2012-11-02 |
2015-10-15 |
Pfizer Inc. |
Bruton's Tyrosine Kinase Inhibitors
|
CN102977014B
(zh)
|
2012-11-05 |
2015-01-07 |
沈阳药科大学 |
新的喹啉类化合物及其用途
|
US20150284381A1
(en)
|
2012-11-07 |
2015-10-08 |
Merck Sharp & Dohme Corp. |
Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
|
WO2014078408A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
US9809578B2
(en)
|
2012-11-13 |
2017-11-07 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors
|
WO2014078322A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
WO2014078372A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
US9790210B2
(en)
|
2012-11-13 |
2017-10-17 |
Array Biopharma Inc. |
N-(monocyclic aryl),N'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
WO2014078378A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
WO2014078328A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
US9969694B2
(en)
|
2012-11-13 |
2018-05-15 |
Array Biopharma Inc. |
N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
PT2922844T
(pt)
|
2012-11-13 |
2018-04-02 |
Array Biopharma Inc |
Compostos de n-pirrolidinil, n'-pirazolil-ureia, tioureia, guanidina e cianoguanidina como inibidores de trka quinase
|
SG11201503842PA
(en)
|
2012-11-15 |
2015-06-29 |
Pharmacyclics Inc |
Pyrrolopyrimidine compounds as kinase inhibitors
|
CN103848810A
(zh)
|
2012-11-30 |
2014-06-11 |
北京赛林泰医药技术有限公司 |
鲁顿酪氨酸激酶抑制剂
|
US20150307491A1
(en)
|
2012-12-07 |
2015-10-29 |
Hutchison Medipharma Limited |
Substituted pyridopyrazines as syk inhibitors
|
EP2931281B1
(en)
|
2012-12-12 |
2018-01-17 |
Merck Sharp & Dohme Corp. |
Amino-pyrimidine-containing spleen tyrosine kinase inhibitors
|
EP2934525B1
(en)
|
2012-12-21 |
2019-05-08 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors
|
WO2014105958A2
(en)
|
2012-12-26 |
2014-07-03 |
Medivation Technologies, Inc. |
Fused pyrimidine compounds and use thereof
|
PL2940014T3
(pl)
|
2012-12-28 |
2019-03-29 |
Crystalgenomics, Inc. |
Pochodne 2,3-dihydro-isoindole-1-on jako supresant kinazy btk i mieszanka farmaceutyczna
|
WO2014111037A1
(zh)
|
2013-01-18 |
2014-07-24 |
上海昀怡健康管理咨询有限公司 |
五元并六元杂环化合物、其制备方法、药物组合物和应用
|
WO2014114185A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2014113932A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2014113942A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
JP6248948B2
(ja)
|
2013-02-08 |
2017-12-20 |
日産化学工業株式会社 |
3環性ピロロピリジン化合物及びjak阻害剤
|
HUE042591T2
(hu)
|
2013-02-19 |
2019-07-29 |
Ono Pharmaceutical Co |
TRK-gátló vegyület
|
AR094812A1
(es)
|
2013-02-20 |
2015-08-26 |
Eisai R&D Man Co Ltd |
Derivado de piridina monocíclico como inhibidor del fgfr
|
WO2014130693A1
(en)
|
2013-02-25 |
2014-08-28 |
Pharmacyclics, Inc. |
Inhibitors of bruton's tyrosine kinase
|
JO3377B1
(ar)
|
2013-03-11 |
2019-03-13 |
Takeda Pharmaceuticals Co |
مشتقات بيريدينيل وبيريدينيل مندمج
|
AU2014249158B2
(en)
|
2013-03-11 |
2016-07-28 |
Ignyta, Inc. |
Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor
|
US9963452B2
(en)
|
2013-03-14 |
2018-05-08 |
Augusta Pharmaceuticals Inc. |
Methods, compounds, and compositions for inhibition of ROS
|
JP6403751B2
(ja)
|
2013-03-14 |
2018-10-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
5−チアゾールカルボキサミン誘導体及びbtk阻害剤としてのその使用
|
WO2014152114A1
(en)
|
2013-03-15 |
2014-09-25 |
Boehringer Ingelheim International Gmbh |
Heteroaromatic compounds as btk inhibitors
|
RU2669922C2
(ru)
|
2013-03-19 |
2018-10-17 |
Мерк Шарп И Доум Корп. |
N-(2-цианогетероциклил)пиразолопиридоны в качестве ингибиторов янус-киназы
|
US9617260B2
(en)
|
2013-04-02 |
2017-04-11 |
Hoffmann-La Roche Inc. |
Inhibitors of bruton's tyrosine kinase
|
TWI628176B
(zh)
|
2013-04-04 |
2018-07-01 |
奧利安公司 |
蛋白質激酶抑制劑
|
US10072298B2
(en)
*
|
2013-04-17 |
2018-09-11 |
Life Technologies Corporation |
Gene fusions and gene variants associated with cancer
|
KR102469849B1
(ko)
|
2013-04-19 |
2022-11-23 |
인사이트 홀딩스 코포레이션 |
Fgfr 저해제로서 이환식 헤테로사이클
|
US9745295B2
(en)
|
2013-04-26 |
2017-08-29 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
WO2014176216A1
(en)
|
2013-04-26 |
2014-10-30 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
|
WO2014180182A1
(zh)
|
2013-05-10 |
2014-11-13 |
江苏豪森药业股份有限公司 |
[1,2,4]三唑并[4,3-a]吡啶类衍生物,其制备方法或其在医药上的应用
|
RS56012B1
(sr)
|
2013-05-17 |
2017-09-29 |
Incyte Corp |
Derivati bipirazola kao inhibitori jak
|
JP6139782B2
(ja)
|
2013-05-21 |
2017-05-31 |
チャンスー メドリューション リミテッド |
置換ピラゾロピリミジン化合物、及びその薬学的に許容される塩、並びにこれらの溶媒和物、立体異性体、及び互変異性体、並びにこれらを含む医薬組成物
|
JP2016520129A
(ja)
|
2013-05-29 |
2016-07-11 |
セファロン、インク. |
Alk阻害剤としてのピロロトリアジン
|
AR096654A1
(es)
|
2013-06-20 |
2016-01-27 |
Ab Science |
Derivados de benzimidazol como inhibidores selectivos de proteína quinasa
|
WO2014204263A1
(en)
|
2013-06-20 |
2014-12-24 |
The Asan Foundation |
Substituted pyridinone compounds as mek inhibitors
|
EP3483167A1
(en)
|
2013-06-26 |
2019-05-15 |
AbbVie Inc. |
Primary carboxamides as btk inhibitors
|
JP6380861B2
(ja)
|
2013-06-28 |
2018-08-29 |
ベイジーン リミテッド |
Rafキナ−ゼおよび/またはRafキナ−ゼの二量体阻害剤としての縮合三環式ウレア系化合物
|
EP3016953A4
(en)
|
2013-07-02 |
2017-03-01 |
Pharmacyclics, LLC |
Purinone compounds as kinase inhibitors
|
TWI649308B
(zh)
|
2013-07-24 |
2019-02-01 |
小野藥品工業股份有限公司 |
喹啉衍生物
|
EP3628749A1
(en)
|
2013-07-30 |
2020-04-01 |
Blueprint Medicines Corporation |
Ntrk2 fusions
|
DK3049417T3
(en)
|
2013-07-31 |
2019-01-14 |
Merck Patent Gmbh |
PYRIDINES, PYRIMIDINES, AND PYRAZINES, AS BTK INHIBITORS AND USES THEREOF
|
MX2016001427A
(es)
|
2013-07-31 |
2016-08-03 |
Gilead Sciences Inc |
Inhibidores de syk.
|
WO2015017607A2
(en)
|
2013-08-02 |
2015-02-05 |
Cephalon, Inc. |
METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR IN COMBINATION WITH OTHER AGENTS
|
TR201802875T4
(tr)
|
2013-08-12 |
2018-03-21 |
Taiho Pharmaceutical Co Ltd |
Yeni kaynaşık pirimidin bileşiği veya tuzu.
|
US9227969B2
(en)
|
2013-08-14 |
2016-01-05 |
Novartis Ag |
Compounds and compositions as inhibitors of MEK
|
US20160361314A1
(en)
|
2013-08-28 |
2016-12-15 |
Novartis Ag |
Combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases
|
JP6458039B2
(ja)
|
2013-09-18 |
2019-01-23 |
北京韓美薬品有限公司 |
Btk及び/又はjak3キナーゼの活性を抑制する化合物
|
WO2015039334A1
(en)
|
2013-09-22 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
WO2015039333A1
(en)
|
2013-09-22 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
SG11201602421VA
(en)
|
2013-09-30 |
2016-04-28 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
EP3059227B1
(en)
|
2013-10-16 |
2019-06-26 |
FUJIFILM Corporation |
Salt of nitrogen-containing heterocyclic compound or crystal thereof, pharmaceutical composition, and flt3 inhibitor
|
CN104341388B
(zh)
|
2013-10-16 |
2017-03-22 |
北京诺诚健华医药科技有限公司 |
芳香族酰胺类衍生物、其制备方法及其在医药上的应用
|
TR201911140T4
(tr)
|
2013-10-21 |
2019-08-21 |
Merck Patent Gmbh |
Btk inhibitörleri olarak heteroaril bileşikleri ve bunların kullanımları.
|
JP6434506B2
(ja)
|
2013-10-21 |
2018-12-05 |
ジェノスコ |
置換ピリミジン化合物およびsyk阻害剤としてのそれらの使用
|
SG11201602183QA
(en)
|
2013-10-25 |
2016-05-30 |
Novartis Ag |
Ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors
|
RU2667892C2
(ru)
|
2013-10-25 |
2018-09-25 |
Шанхай Хэнжуй Фармасьютикал Ко., Лтд. |
Производные пиридилкетона, способ их получения и их фармацевтическое применение
|
WO2015068767A1
(ja)
|
2013-11-08 |
2015-05-14 |
小野薬品工業株式会社 |
ピロロピリミジン誘導体
|
CN104447640B
(zh)
|
2013-12-02 |
2016-07-13 |
北京键凯科技有限公司 |
3-呋喃基-2-氰基-2-丙烯酰胺衍生物及其制备方法、药物组合物和用途
|
CA2932609A1
(en)
|
2013-12-05 |
2015-06-11 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
TWI731317B
(zh)
|
2013-12-10 |
2021-06-21 |
美商健臻公司 |
原肌球蛋白相關之激酶(trk)抑制劑
|
WO2015094997A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
US9637486B2
(en)
|
2013-12-20 |
2017-05-02 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2015095444A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
WO2015095445A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
US9834554B2
(en)
|
2013-12-20 |
2017-12-05 |
Merck Sharp & Dohme Corp. |
BTK inhibitors
|
UY35898A
(es)
|
2013-12-23 |
2015-07-31 |
Gilead Sciences Inc |
?compuestos inhibidores de syk y composiciones que los comprenden?.
|
EA029757B1
(ru)
|
2013-12-26 |
2018-05-31 |
Игнита, Инк. |
ПРОИЗВОДНЫЕ ПИРАЗОЛО[1,5-a]ПИРИДИНА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
JP6486954B2
(ja)
|
2014-01-29 |
2019-03-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Btk阻害剤としてのピラゾール化合物
|
JP6162904B2
(ja)
|
2014-02-03 |
2017-07-12 |
カディラ ヘルスケア リミティド |
新規複素環式化合物
|
RS60150B1
(sr)
|
2014-02-04 |
2020-05-29 |
Astellas Pharma Inc |
Medicinska kompozicija koja obuhvata diamino heterociklično jedinjenje karboksamida kao aktivni sastojak
|
US9783539B2
(en)
|
2014-02-27 |
2017-10-10 |
Jiangsu Ascentage Biomed Development Inc. |
Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhibitors
|
US9775839B2
(en)
|
2014-03-13 |
2017-10-03 |
Merck Sharp & Dohme Corp. |
2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
|
DK3119772T3
(da)
|
2014-03-19 |
2019-08-26 |
Boehringer Ingelheim Int |
Heteroaryl syk-hæmmere
|
CA2943316A1
(en)
|
2014-03-24 |
2015-10-01 |
Ab Science |
Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors
|
WO2015143652A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
WO2015143653A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
WO2015143654A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
BR112016021507B1
(pt)
|
2014-03-27 |
2022-10-18 |
Janssen Pharmaceutica Nv |
Derivados de 4,5,6,7-tetra-hidro-pirazolo[1,5-a]pirimidina substituídos e derivados de 2,3-dihidro-1himidazo[1,2-b]pirazol como inibidores do ros1 e composição farmacêutica que os compreende
|
WO2015144799A1
(en)
|
2014-03-27 |
2015-10-01 |
Janssen Pharmaceutica Nv |
SUBSTITUTED 4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-a]PYRAZINE DERIVATIVES AND 5,6,7,8-TETRAHYDRO-4H-PYRAZOLO[1,5-a][1,4]DIAZEPINE DERIVATIVES AS ROS1 INHIBITORS
|
US20170137426A1
(en)
|
2014-03-28 |
2017-05-18 |
Changzhou Jiekai Pharmatech Co., Ltd. |
Heterocyclic compounds as axl inhibitors
|
CN105017256A
(zh)
|
2014-04-29 |
2015-11-04 |
浙江导明医药科技有限公司 |
多氟化合物作为布鲁顿酪氨酸激酶抑制剂
|
CN105085474B
(zh)
|
2014-05-07 |
2018-05-18 |
北京赛林泰医药技术有限公司 |
鲁顿酪氨酸激酶抑制剂
|
NZ725001A
(en)
|
2014-05-14 |
2021-08-27 |
Nissan Chemical Ind Ltd |
Tricyclic compound and jak inhibitor
|
RS59286B1
(sr)
|
2014-05-15 |
2019-10-31 |
Array Biopharma Inc |
1-((3s,4r)-4-(3-fluorofenil)-1-(2-metoksietil)pirolidin-3-il)-3-(4-metil-3-(2-metilpirimidin-5-il)-1-fenil-1h-pirazol-5-il)urea kao inhibitor trka kinaze
|
WO2015180685A1
(zh)
|
2014-05-30 |
2015-12-03 |
北京浦润奥生物科技有限责任公司 |
Alk激酶抑制剂及其制备方法和应用
|
WO2015194764A2
(ko)
|
2014-06-17 |
2015-12-23 |
한국화학연구원 |
피리미딘-2,4-디아민 유도체 및 이를 유효성분으로 함유하는 항암용 약학적 조성물
|
WO2015200341A1
(en)
|
2014-06-23 |
2015-12-30 |
Dr. Reddy's Laboratories Ltd. |
Substituted imidazo[1,2-a]pyridine compounds useful for the treatment of pain
|
TWI723572B
(zh)
|
2014-07-07 |
2021-04-01 |
日商第一三共股份有限公司 |
具有四氫吡喃基甲基之吡啶酮衍生物及其用途
|
TW201617074A
(zh)
|
2014-07-14 |
2016-05-16 |
吉李德科學股份有限公司 |
Syk(脾酪胺酸激酶)抑制劑
|
AU2015296215A1
(en)
|
2014-08-01 |
2017-03-23 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
WO2016021629A1
(ja)
|
2014-08-06 |
2016-02-11 |
塩野義製薬株式会社 |
TrkA阻害活性を有する複素環および炭素環誘導体
|
NO2721710T3
(US07655688-20100202-C00086.png)
|
2014-08-21 |
2018-03-31 |
|
|
KR101710127B1
(ko)
|
2014-08-29 |
2017-02-27 |
한화제약주식회사 |
야누스인산화효소 억제제로서의 치환된 N-(피롤리딘-3-일)-7H-피롤로[2,3-d]피리미딘-4-아민
|
EP3188729A1
(en)
|
2014-09-03 |
2017-07-12 |
Genzyme Corporation |
Cyclic urea compounds as tropomyosin-related kinase (trk) inhibitors
|
CN105524068B
(zh)
|
2014-09-30 |
2017-11-24 |
上海海雁医药科技有限公司 |
氮杂双环衍生物、其制法与医药上的用途
|
JP6585167B2
(ja)
|
2014-10-03 |
2019-10-02 |
ノバルティス アーゲー |
Fgfr4阻害剤としての縮環二環式ピリジル誘導体の使用
|
SG11201701573QA
(en)
|
2014-10-06 |
2017-03-30 |
Merck Patent Gmbh |
Heteroaryl compounds as btk inhibitors and uses thereof
|
CN117069700A
(zh)
|
2014-10-11 |
2023-11-17 |
上海翰森生物医药科技有限公司 |
Egfr抑制剂及其制备和应用
|
KR102519536B1
(ko)
|
2014-10-24 |
2023-04-06 |
브리스톨-마이어스 스큅 컴퍼니 |
트리시클릭 회전장애이성질체 화합물
|
CA2965559A1
(en)
|
2014-10-30 |
2016-05-06 |
Sandoz Ag |
Active acrylamides
|
CN105085489B
(zh)
|
2014-11-05 |
2019-03-01 |
益方生物科技(上海)有限公司 |
嘧啶或吡啶类化合物、其制备方法和医药用途
|
EP3221309B1
(en)
|
2014-11-20 |
2019-11-13 |
Council of Scientific and Industrial Research |
Novel benzimidazole based egfr inhibitors
|
CN105601573B
(zh)
|
2014-11-24 |
2021-07-02 |
中国科学院上海药物研究所 |
2-氨基嘧啶类化合物及其药物组合物和应用
|
JP2017538708A
(ja)
|
2014-12-11 |
2017-12-28 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
pan FGFR阻害剤の使用およびpan FGFR阻害剤を用いる治療に適格な癌を有する患者を同定する方法
|
EP3233829B1
(en)
|
2014-12-18 |
2019-08-14 |
Pfizer Inc |
Pyrimidine and triazine derivatives and their use as axl inhibitors
|
ES2749726T3
(es)
|
2014-12-25 |
2020-03-23 |
Ono Pharmaceutical Co |
Derivado de quinolina
|
WO2016106652A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Biarylether imidazopyrazine btk inhibitors
|
WO2016106624A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Tertiary alcohol imidazopyrazine btk inhibitors
|
WO2016106629A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2016106626A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Imidazopyrazine analogs with 3-tertiary carbon substitutions as btk inhibitors
|
WO2016106628A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2016106627A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2016106623A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Benzamide imidazopyrazine btk inhibitors
|
CN104530063B
(zh)
|
2015-01-13 |
2017-01-18 |
北京赛特明强医药科技有限公司 |
喹唑啉并杂环类化合物及其制备方法和作为用于治疗癌症的表皮生长因子受体抑制剂的应用
|
CN105837576B
(zh)
|
2015-01-14 |
2019-03-26 |
湖北生物医药产业技术研究院有限公司 |
Btk抑制剂
|
KR101864561B1
(ko)
|
2015-01-20 |
2018-06-04 |
우시 포춘 파마슈티컬 컴퍼니 리미티드 |
Jak 억제제
|
US10336723B2
(en)
|
2015-01-23 |
2019-07-02 |
Gvk Biosciences Private Limited |
Inhibitors of TrkA kinase
|
JP2018504441A
(ja)
|
2015-02-03 |
2018-02-15 |
トリリウム セラピューティクス インコーポレイテッド |
癌の治療に有用なegfr阻害剤としての新規フッ素化誘導体
|
WO2016125186A1
(en)
|
2015-02-03 |
2016-08-11 |
Council Of Scientific & Industrial Research |
Novel flavone based egfr inhibitors and process for preparation thereof
|
EA038045B1
(ru)
|
2015-02-20 |
2021-06-28 |
Инсайт Корпорейшн |
Бициклические гетероциклы в качестве ингибиторов fgfr
|
WO2016161570A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Azacarbazole btk inhibitors
|
WO2016161572A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
WO2016161571A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Indazole and azaindazole btk inhibitors
|
JP6654646B2
(ja)
|
2015-04-14 |
2020-02-26 |
キュリエント カンパニー, リミテッド |
Tam rtkインヒビターとしてのキノリン誘導体
|
ES2734048T3
(es)
|
2015-04-29 |
2019-12-04 |
Wuxi Fortune Pharmaceutical Co Ltd |
Inhibidores de Janus cinasas (JAK)
|
ME03610B
(me)
|
2015-05-28 |
2020-07-20 |
Theravance Biopharma R&D Ip Llc |
Naftiridinska jedinjenja kao inhibitori jak kinaze
|
EP3305788B1
(en)
|
2015-05-29 |
2020-08-05 |
Wuxi Fortune Pharmaceutical Co., Ltd |
Janus kinase inhibitor
|
BR112017025986A2
(pt)
|
2015-06-02 |
2018-08-14 |
Pharmacyclics Llc |
inibidores de tirosina quinase de bruton.
|
AU2016270973B2
(en)
|
2015-06-03 |
2020-05-14 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
WO2016192074A1
(en)
|
2015-06-04 |
2016-12-08 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
EP3313839A1
(en)
|
2015-06-24 |
2018-05-02 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
MX2017016772A
(es)
|
2015-07-07 |
2018-05-14 |
Japan Tobacco Inc |
Metodo para producir un derivado de 7h-pirrolo[2,3-d]pirimidina e intermediario del mismo.
|
EP3330256B1
(en)
|
2015-07-07 |
2021-06-16 |
Shionogi & Co., Ltd. |
HETEROCYCLIC DERIVATIVE HAVING TrkA-INHIBITING ACTIVITY
|
ES2854703T3
(es)
|
2015-07-09 |
2021-09-22 |
Merck Patent Gmbh |
Compuestos de heteroarilo como inhibidores de BTK y usos de los mismos
|
AU2016292450B2
(en)
|
2015-07-16 |
2021-03-25 |
Centaurus Biopharma Co., Ltd. |
Aniline pyrimidine derivatives and uses thereof
|
PT3322706T
(pt)
|
2015-07-16 |
2021-03-08 |
Array Biopharma Inc |
Compostos de pirazolo[1,5-a]piridina substituídos como inibidores da quinase do ret
|
AU2016296877B2
(en)
|
2015-07-20 |
2020-09-17 |
Dana-Farber Cancer Institute, Inc. |
Novel pyrimidines as EGFR inhibitors and methods of treating disorders
|
DK3325623T6
(da)
*
|
2015-07-23 |
2021-03-15 |
Inst Curie |
Anvendelse af en kombination af dbait-molekyle og parp-inhibitorer til behandling af kræft
|
US10561646B2
(en)
|
2015-07-24 |
2020-02-18 |
Shanghai Haiyan Pharmaceutical Technology Co. Ltd. |
EGFR inhibitor and pharmaceutically acceptable salt and polymorph thereof, and use thereof
|
KR101766194B1
(ko)
|
2015-08-07 |
2017-08-10 |
한국과학기술연구원 |
RET 키나아제 저해제인 신규 3-(이속사졸-3-일)-피라졸로[3,4-d]피리미딘-4-아민 화합물
|
CN106467541B
(zh)
|
2015-08-18 |
2019-04-05 |
暨南大学 |
取代喹诺酮类衍生物或其药学上可接受的盐或立体异构体及其药用组合物和应用
|
CN107406431B
(zh)
|
2015-08-20 |
2020-06-26 |
上海昂睿医药技术有限公司 |
吲哚类衍生物及其制备方法和其在医药上的用途
|
MA41559A
(fr)
|
2015-09-08 |
2017-12-26 |
Taiho Pharmaceutical Co Ltd |
Composé de pyrimidine condensé ou un sel de celui-ci
|
MX2018003351A
(es)
|
2015-09-16 |
2018-09-17 |
Loxo Oncology Inc |
Derivados de pirazolopirimidina como inhibidores de la btk para el tratramiento de cancer.
|
EP3144307A1
(en)
|
2015-09-18 |
2017-03-22 |
AB Science |
Novel oxazole derivatives that inhibit syk
|
CN106554347B
(zh)
|
2015-09-25 |
2020-10-30 |
浙江博生医药有限公司 |
Egfr激酶抑制剂及其制备方法和应用
|
US10526309B2
(en)
|
2015-10-02 |
2020-01-07 |
The University Of North Carolina At Chapel Hill |
Pan-TAM inhibitors and Mer/Axl dual inhibitors
|
CN108349940B
(zh)
|
2015-10-14 |
2021-08-13 |
淄博百极常生制药有限公司 |
布鲁顿酪氨酸激酶抑制剂
|
US10208024B2
(en)
|
2015-10-23 |
2019-02-19 |
Array Biopharma Inc. |
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases
|
CA3001542C
(en)
|
2015-11-03 |
2021-02-16 |
Theravance Biopharma R&D Ip, Llc |
Jak kinase inhibitor compounds for treatment of respiratory disease
|
CN106699743B
(zh)
|
2015-11-05 |
2020-06-12 |
湖北生物医药产业技术研究院有限公司 |
嘧啶类衍生物及其用途
|
EP3371189A1
(en)
|
2015-11-06 |
2018-09-12 |
Acerta Pharma B.V. |
Imidazopyrazine inhibitors of bruton's tyrosine kinase
|
MX2018006195A
(es)
|
2015-11-19 |
2018-09-05 |
Blueprint Medicines Corp |
Compuestos y composiciones utiles para el tratamiento de trastornos relacionados con ntrk.
|
MX2018006282A
(es)
|
2015-11-24 |
2019-01-21 |
Theravance Biopharma R&D Ip Llc |
Profarmacos de un compuesto inhibidor de jak para el tratamiento de la enfermedad inflamatoria gastrointestinal.
|
ES2830446T3
(es)
|
2015-12-11 |
2021-06-03 |
Sichuan Kelun Biotech Biopharmaceutical Co Ltd |
Derivado de azetidina, método de preparación del mismo y uso del mismo
|
HUE056877T2
(hu)
|
2015-12-16 |
2022-03-28 |
Boehringer Ingelheim Int |
Autoimmun betegségek kezelésére alkalmas bipirazolil-származékok
|
CN106928231B
(zh)
|
2015-12-31 |
2021-06-01 |
合肥中科普瑞昇生物医药科技有限公司 |
一类新型的egfr野生型和突变型的激酶抑制剂
|
CN108779079A
(zh)
|
2016-01-06 |
2018-11-09 |
特里乌姆治疗公司 |
作为egfr抑制剂的新的氟化喹唑啉衍生物
|
LT3402792T
(lt)
|
2016-01-11 |
2021-12-10 |
Merck Patent Gmbh |
Chinolin-2-ono dariniai
|
EP3402789B1
(en)
|
2016-01-13 |
2020-03-18 |
Boehringer Ingelheim International Gmbh |
Isoquinolones as btk inhibitors
|
EP3405192A4
(en)
|
2016-01-21 |
2019-07-03 |
Zibo Biopolar Changsheng Pharmaceutical Co. Ltd. |
INHIBITORS OF BRUTON TYROSINE KINASE
|
JP6770580B2
(ja)
|
2016-01-26 |
2020-10-14 |
杭州華東医薬集団生物医薬有限公司Hangzhou Huadong Medicine Group Biopharmaceutical Co., Ltd. |
ピロロピリミジン5員環アザ環状誘導体およびその利用
|
CN107021963A
(zh)
|
2016-01-29 |
2017-08-08 |
北京诺诚健华医药科技有限公司 |
吡唑稠环类衍生物、其制备方法及其在治疗癌症、炎症和免疫性疾病上的应用
|
EP3412663B1
(en)
|
2016-02-04 |
2022-09-07 |
Shionogi & Co., Ltd. |
Nitrogen-containing heterocycle and carbocycle derivatives having trka inhibitory activity
|
US10786507B2
(en)
|
2016-02-19 |
2020-09-29 |
Jiangsu Hengrui Medicine Co., Ltd. |
Pharmaceutical composition containing JAK kinase inhibitor or pharmaceutically acceptable salt thereof
|
AU2017222908B2
(en)
|
2016-02-23 |
2021-02-04 |
Taiho Pharmaceutical Co., Ltd. |
Novel condensed pyrimidine compound or salt thereof
|
CA3016355A1
(en)
*
|
2016-03-01 |
2017-09-08 |
Onxeo |
Treatment of cancer by systemic administration of dbait molecules
|
CN107151249B
(zh)
|
2016-03-04 |
2020-08-14 |
华东理工大学 |
作为flt3抑制剂的蝶啶酮衍生物及应用
|
WO2017161269A1
(en)
|
2016-03-17 |
2017-09-21 |
Blueprint Medicines Corporation |
Inhibitors of ret receptor tyrosine kinases
|
CN107286077B
(zh)
|
2016-04-01 |
2021-04-02 |
合肥中科普瑞昇生物医药科技有限公司 |
一种选择性的c-kit激酶抑制剂
|
US20200339562A1
(en)
|
2016-04-29 |
2020-10-29 |
X-Chem, Inc. |
Covalent btk inhibitors and uses thereof
|
AR110038A1
(es)
|
2016-05-26 |
2019-02-20 |
Kalyra Pharmaceuticals Inc |
Compuestos inhibidores de egfr; composición farmacéutica que lo comprende; métodos para mejorar o tratar un cáncer; método para inhibir la replicación de un crecimiento maligno o un tumor; métodos para inhibir la actividad del egfr; y usos de los compuestos
|
CN107759600A
(zh)
|
2016-06-16 |
2018-03-06 |
正大天晴药业集团股份有限公司 |
作为jak抑制剂的吡咯并嘧啶化合物的结晶
|
WO2018001251A1
(zh)
|
2016-06-27 |
2018-01-04 |
杭州雷索药业有限公司 |
苯并呋喃吡唑胺类蛋白激酶抑制剂
|
WO2018002958A1
(en)
|
2016-06-30 |
2018-01-04 |
Sun Pharma Advanced Research Company Limited |
Novel hydrazide containing compounds as btk inhibitors
|
ES2878973T3
(es)
|
2016-06-30 |
2021-11-19 |
Hangzhou Bangshun Pharmaceutical Co Ltd |
Derivado de fenilo de imidazopiridinamina y uso del mismo
|
US10399988B2
(en)
|
2016-07-07 |
2019-09-03 |
Daewoong Pharmaceutical Co., Ltd. |
4-aminopyrazolo[3,4-d]pyrimidinylazabicyclo derivatives and pharmaceutical composition comprising the same
|
CN107619388A
(zh)
|
2016-07-13 |
2018-01-23 |
南京天印健华医药科技有限公司 |
作为fgfr抑制剂的杂环化合物
|
US10227329B2
(en)
|
2016-07-22 |
2019-03-12 |
Blueprint Medicines Corporation |
Compounds useful for treating disorders related to RET
|
US10035789B2
(en)
|
2016-07-27 |
2018-07-31 |
Blueprint Medicines Corporation |
Compounds useful for treating disorders related to RET
|
CN107698593A
(zh)
|
2016-08-09 |
2018-02-16 |
南京天印健华医药科技有限公司 |
作为fgfr抑制剂的杂环化合物
|
CA3034239A1
(en)
|
2016-08-16 |
2018-02-22 |
Merck Patent Gmbh |
2-oxo-imidazopyridines as reversible btk inhibitors and uses thereof
|
AU2017319135B2
(en)
|
2016-08-29 |
2021-03-18 |
The Regents Of The University Of Michigan |
Aminopyrimidines as ALK inhibitors
|
US10111882B2
(en)
|
2016-09-14 |
2018-10-30 |
Gilead Sciences, Inc. |
SYK inhibitors
|
TW201822764A
(zh)
|
2016-09-14 |
2018-07-01 |
美商基利科學股份有限公司 |
Syk抑制劑
|
CN107840846B
(zh)
|
2016-09-19 |
2020-11-24 |
郑州泰基鸿诺医药股份有限公司 |
一种含嘧啶环的化合物、egfr抑制剂及其应用
|
CN107840842A
(zh)
|
2016-09-19 |
2018-03-27 |
北京天诚医药科技有限公司 |
炔代杂环化合物、其制备方法及其在医药学上的应用
|
JP2018052878A
(ja)
|
2016-09-29 |
2018-04-05 |
第一三共株式会社 |
ピリジン化合物
|
JOP20190077A1
(ar)
|
2016-10-10 |
2019-04-09 |
Array Biopharma Inc |
مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret
|
TWI704148B
(zh)
|
2016-10-10 |
2020-09-11 |
美商亞雷生物製藥股份有限公司 |
作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
|
WO2018079759A1
(ja)
|
2016-10-31 |
2018-05-03 |
塩野義製薬株式会社 |
TrkA阻害活性を有する縮合複素環および縮合炭素環誘導体
|
KR20180051220A
(ko)
|
2016-11-08 |
2018-05-16 |
주식회사 대웅제약 |
신규한 피롤로피리미딘 유도체 및 이를 포함하는 약학적 조성물
|
WO2018090792A1
(zh)
|
2016-11-15 |
2018-05-24 |
杭州和正医药有限公司 |
一种选择性布鲁顿酪氨酸激酶抑制剂及其应用
|
CA3044384A1
(en)
|
2016-11-18 |
2018-05-24 |
The Regents Of The University Of Michigan |
5,6-dihydro-11h-indolo[2,3-b]quinolin-11-ones as alk inhibitors
|
CN108101905A
(zh)
|
2016-11-24 |
2018-06-01 |
中国科学院上海药物研究所 |
嘧啶并[5,4-b]吲嗪或嘧啶并[5,4-b]吡呤化合物、其制备方法及用途
|
US11142535B2
(en)
|
2016-12-12 |
2021-10-12 |
Hangzhou Innogate Pharma Co., Ltd. |
Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitor
|
WO2018108064A1
(zh)
|
2016-12-13 |
2018-06-21 |
南京明德新药研发股份有限公司 |
作为第四代egfr激酶抑制剂的螺环芳基磷氧化合物
|
AU2017376629B2
(en)
|
2016-12-15 |
2021-11-25 |
Ariad Pharmaceuticals, Inc. |
Benzimidazole compounds as c-Kit inhibitors
|
MX2019007079A
(es)
|
2016-12-15 |
2019-10-15 |
Ariad Pharma Inc |
Compuestos de aminotiazol como inhibidores de c- kit.
|
CN108250200A
(zh)
|
2016-12-28 |
2018-07-06 |
中国科学院上海药物研究所 |
一种具有Axl抑制活性的化合物及其制备和应用
|
WO2018121650A1
(zh)
|
2016-12-29 |
2018-07-05 |
南京明德新药研发股份有限公司 |
Fgfr抑制剂
|
EP3567030B1
(en)
|
2016-12-30 |
2022-02-09 |
Medshine Discovery Inc. |
Quinazoline compound for egfr inhibition
|
CN108276410B
(zh)
|
2017-01-06 |
2021-12-10 |
首药控股(北京)股份有限公司 |
一种间变性淋巴瘤激酶抑制剂及其制备方法和用途
|
EP3568132A4
(en)
|
2017-01-10 |
2020-09-09 |
Wang, Wei |
MODULATION BY LASOFOXIFEN OF EESTROGENIC SIGNALS OF MEMBRANARY ORIGIN AND METHODS FOR THE TREATMENT OF TUMORS
|
CA3049136C
(en)
|
2017-01-18 |
2022-06-14 |
Array Biopharma Inc. |
Substituted pyrazolo[1,5-a]pyrazine compounds as ret kinase inhibitors
|
WO2018136663A1
(en)
|
2017-01-18 |
2018-07-26 |
Array Biopharma, Inc. |
Ret inhibitors
|
CN106831787B
(zh)
|
2017-01-20 |
2018-10-23 |
成都倍特药业有限公司 |
用作布鲁顿酪氨酸激酶抑制剂的化合物及其制备方法和应用
|
US11608334B2
(en)
|
2017-02-08 |
2023-03-21 |
The National Institutes of Pharmaceutical R&D Co., Ltd. |
Pyrrolo-aromatic heterocyclic compound, preparation method therefor, and medical use thereof
|
US10464923B2
(en)
|
2017-02-27 |
2019-11-05 |
Merck Patent Gmbh |
Crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-piperidin-1-yl)-propenone
|
TWI741155B
(zh)
|
2017-02-27 |
2021-10-01 |
大陸商貝達藥業股份有限公司 |
Fgfr抑制劑及其應用
|
WO2018153293A1
(zh)
|
2017-02-27 |
2018-08-30 |
北京赛特明强医药科技有限公司 |
二噁烷并喹唑啉与二噁烷并喹啉类化合物及其制备方法与应用
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
WO2018175512A1
(en)
|
2017-03-22 |
2018-09-27 |
Suzhou Baijibugong Pharmaceutical Technology Co. Ltd. |
Bruton's tyrosine kinase inhibitors
|
WO2018187355A1
(en)
|
2017-04-03 |
2018-10-11 |
Health Research Inc. |
Met kinase inhibitors and uses therefor
|
CN108721298A
(zh)
|
2017-04-19 |
2018-11-02 |
华东理工大学 |
作为布鲁顿酪氨酸激酶抑制剂的嘧啶并杂环化合物及其应用
|
CN108727382B
(zh)
|
2017-04-19 |
2022-07-19 |
华东理工大学 |
作为btk抑制剂的杂环化合物及其应用
|
CN107043366B
(zh)
|
2017-04-25 |
2020-05-26 |
中国药科大学 |
4-氨基嘧啶类化合物、其制备方法及医药用途
|
CN110831926B
(zh)
|
2017-04-27 |
2023-11-21 |
持田制药株式会社 |
新型四氢萘基脲衍生物
|
AR111495A1
(es)
|
2017-05-01 |
2019-07-17 |
Theravance Biopharma R&D Ip Llc |
Compuestos de imidazo-piperidina fusionada como inhibidores de jak
|
WO2018208132A1
(en)
|
2017-05-12 |
2018-11-15 |
Korea Research Institute Of Chemical Technology |
Pyrazolopyrimidine derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer, autoimmune disease and brain disease containing the same as an active ingredient
|
WO2018215390A1
(en)
|
2017-05-22 |
2018-11-29 |
F. Hoffmann-La Roche Ag |
Therapeutic compounds and compositions, and methods of use thereof
|
AU2018274577A1
(en)
|
2017-05-22 |
2019-10-10 |
F. Hoffmann-La Roche Ag |
Therapeutic compounds and compositions, and methods of use thereof
|
CN107176954B
(zh)
|
2017-06-02 |
2019-01-11 |
无锡双良生物科技有限公司 |
一种egfr抑制剂的药用盐及其晶型、制备方法和应用
|
CN110678461B
(zh)
|
2017-06-14 |
2021-08-10 |
正大天晴药业集团股份有限公司 |
Syk抑制剂及其使用方法
|
CN109111446B
(zh)
|
2017-06-22 |
2021-11-30 |
上海度德医药科技有限公司 |
一种具有药物活性的杂芳基化合物
|
BR112019027676A2
(pt)
|
2017-06-27 |
2020-09-15 |
Janssen Pharmaceutica Nv |
compostos de quinolinona
|
CN111093645A
(zh)
|
2017-07-05 |
2020-05-01 |
Cs制药技术有限公司 |
Egfr酪氨酸激酶的临床上重要的突变体的选择性抑制剂
|
CN110997677A
(zh)
|
2017-08-12 |
2020-04-10 |
百济神州有限公司 |
具有改进的双重选择性的Btk抑制剂
|
WO2019034075A1
(zh)
|
2017-08-15 |
2019-02-21 |
南京明德新药研发股份有限公司 |
Fgfr和egfr抑制剂
|
US11236094B2
(en)
|
2017-08-15 |
2022-02-01 |
Cspc Zhongqi Pharmaceuticall Technology (Shijiazhuang) Co., Ltd. |
Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitors
|
CN109400610A
(zh)
|
2017-08-18 |
2019-03-01 |
浙江海正药业股份有限公司 |
吡咯并三嗪类衍生物、其制备方法及其在医药上的用途
|
KR20200041954A
(ko)
|
2017-08-18 |
2020-04-22 |
북경한미약품 유한공사 |
화합물, 이의 약제학적 조성물, 및 이의 용도 및 응용
|
WO2019034538A1
(en)
|
2017-08-18 |
2019-02-21 |
Universität Regensburg |
SYNTHESIS, PHARMACOLOGY AND USE OF NEW FMS FLT3 TYROSINE KINASE 3 (FLT3) SELECTIVE INHIBITORS
|